ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	51/1472	73/5963	3.68259869760402e-16	1.99596849410138e-13	1.63584910567252e-13	6356/6357/6358/6361/6362/6363/6347/6364/6367/6369/6370/10344/6348/6351/9560/6355/1437/1440/6376/2919/3627/6373/284340/2920/2921/6374/6372/4283/10148/3458/3586/3589/3605/3606/29949/3552/3553/3557/51561/11009/90865/3569/4049/4312/4314/4318/5008/5196/6696/7124/10673	51
WP2806	Complement system	47/1472	75/5963	2.67579569588284e-12	7.25140633584248e-10	5.94308307190819e-10	133/335/715/716/717/718/720/722/728/27202/729/811/958/1604/966/22918/629/1675/3426/5199/1378/2159/2160/2214/2219/2357/2769/3383/3384/3673/3687/3689/3690/3818/3911/3915/5648/5329/5806/6401/6402/6403/6404/710/6696/7097/7454	47
WP5055	Burn wound healing	51/1472	93/5963	3.50697676056792e-10	6.33593801409271e-08	5.19278664196373e-08	8038/6347/57124/1139/1265/1277/1278/2919/3579/2006/2200/2261/60674/3082/3383/3552/3553/3569/3624/3791/3853/23643/440823/407024/4312/4322/4313/79148/4314/4318/100463486/64332/64127/5159/6282/6280/6423/6678/6876/7042/7043/7076/7096/7097/7099/51311/54106/3371/7124/7128/7431	51
WP5218	Extrafollicular B cell activation by SARS-CoV-2	39/1472	65/5963	1.273568462409e-09	1.7256852665642e-07	1.41433129246474e-07	57379/604/718/720/6363/958/969/973/941/3732/1378/10148/2113/83416/1880/29851/3433/8519/3455/3458/100885789/3586/3569/3662/9636/3687/3689/4240/5133/639/5788/6402/57823/6776/30009/7099/7124/10673/7494	39
WP5115	Network map of SARS-CoV-2 signaling pathway	83/1472	190/5963	4.63252199534399e-09	5.02165384295288e-07	4.11563006744245e-07	59272/183/335/350/8542/332/684/11119/715/716/84433/838/841/6356/6347/6364/6367/10344/6348/6351/6355/891/10666/983/1051/629/3426/5199/1294/1514/2919/3627/2920/2921/6374/6372/4283/3577/3579/54541/84985/2247/2534/51512/3091/3122/3123/3429/10964/8519/10410/3458/3486/3586/3605/3606/8807/3552/3553/90865/3569/10379/3699/3717/3726/116844/64386/4791/22861/114548/4939/5196/5743/6241/6288/6289/6403/5054/6772/7124/7173/7216/7535	83
WP3624	Lung fibrosis	32/1472	52/5963	1.65783940308478e-08	1.49758159411991e-06	1.2273828563189e-06	23250/6356/6347/6348/6351/729230/1232/1051/1437/1440/2920/57105/1906/2006/2246/2247/2252/26585/3082/3553/3569/4313/4318/4502/5155/5328/5806/6498/6696/7015/7076/7124	32
WP2865	IL1 and megakaryocytes in obesity	18/1472	23/5963	9.66824504028058e-08	7.48598401690296e-06	6.13533745413294e-06	6347/1232/2149/2205/1839/3383/3458/3606/3553/3554/4318/114548/7941/6280/8991/7076/7096/7097	18
WP2911	miRNA targets in ECM and membrane receptors	17/1472	22/5963	3.10498337814002e-07	2.10362623868986e-05	1.72408287575669e-05	1278/1281/1282/1284/1289/1290/50509/1291/1292/1293/3672/22801/3694/3910/3913/3915/7058	17
WP2328	Allograft rejection	39/1472	76/5963	4.46529098036655e-07	2.68909745706519e-05	2.20392139615752e-05	5243/185/23743/717/718/720/721/729/841/6363/940/958/1604/941/942/1289/1493/6373/4283/50943/10578/3002/3108/3112/3119/3122/3123/3134/3458/3586/3605/3552/3553/3559/120892/5551/6772/7124/7431	39
WP2877	Vitamin D receptor pathway	62/1472	143/5963	5.91724285096249e-07	3.16694788998162e-05	2.59555643731257e-05	5243/11096/147/240/248/604/768/838/875/898/958/1029/1030/634/9075/1493/1594/1559/1565/29785/1576/168002/1673/11221/1946/50486/727936/3091/3123/3294/3486/3488/9173/3662/3684/3726/5653/3827/126364/4600/5368/639/5744/10125/6273/6279/6280/1992/10568/219855/25928/6696/6699/79689/412/6822/7042/7056/7078/7128/4982/54210	62
WP558	Complement and coagulation cascades	28/1472	48/5963	6.42738501656786e-07	3.16694788998162e-05	2.59555643731257e-05	715/716/717/718/721/728/729/1604/629/1675/3426/1191/1378/2159/2149/2152/2155/3818/3827/5648/5328/5329/5624/5054/5345/710/7056/7450	28
WP619	Type II interferon signaling	22/1472	34/5963	8.70343953051352e-07	3.93105352128194e-05	3.22179954550588e-05	4261/3627/4283/1536/2633/3383/3433/3458/3553/3659/3662/10379/9636/3717/4843/5698/5967/8651/9021/6688/6772/6890	22
WP5198	Inflammatory bowel disease signaling	22/1472	35/5963	1.79949109207101e-06	7.50249363001914e-05	6.14886834699568e-05	50943/3108/3458/3586/3594/3595/3606/8807/3552/50615/51561/3569/4772/64127/6097/6772/6774/6775/30009/7097/7099/7124	22
WP5090	Complement system in neuronal development and plasticity	43/1472	93/5963	4.31813087379582e-06	0.00016717335239981	0.000137011370582093	57194/23250/57198/148229/715/716/717/718/720/721/722/725/728/27202/729/843/841/1604/966/629/1675/3426/5199/1191/10584/1378/286204/6376/9787/2219/8547/3458/3684/3685/3687/3689/3690/5648/4240/5359/710/7042/7043	43
WP455	GPCRs, class A rhodopsin-like	51/1472	118/5963	6.59758807746516e-06	0.000238392849199074	0.000195381204820372	1238/51554/134/147/150/185/187/27202/1230/729230/1232/1233/1237/10803/1131/3577/3579/2833/10800/57105/1909/2149/2151/9002/2867/2357/2358/2842/2828/8477/8111/54329/8843/3274/3363/1241/4543/5540/27334/53829/9934/5030/5031/5724/5729/5737/5739/266747/6751/6752/56670	51
WP4891	COVID-19 adverse outcome pathway	11/1472	13/5963	9.45237256857626e-06	0.000310380480600097	0.000254380584216821	59272/183/6347/6348/1440/3627/3586/3553/3559/3569/7124	11
WP4462	Platelet-mediated interactions with vascular and circulating cells	13/1472	17/5963	1.03078388391176e-05	0.000310380480600097	0.000254380584216821	6347/958/3383/3553/5196/6401/6403/6404/7042/7043/7097/7099/7412	13
WP691	Tamoxifen metabolism	13/1472	17/5963	1.03078388391176e-05	0.000310380480600097	0.000254380584216821	1545/1557/1558/1559/1565/1576/2326/2328/6817/6822/54575/54657/7364	13
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	96/1472	265/5963	1.21522771743031e-05	0.000346659696235383	0.000284114181028028	10000/285/1101/1302/1277/1278/1280/1281/1282/1284/1286/1289/1290/50509/1292/64764/84699/9586/1440/1441/54541/1942/1946/1969/2149/2246/2255/2259/2247/2252/2254/2261/2321/2324/2690/2784/59345/51764/2786/3082/3091/7184/3455/3559/3560/3563/3575/22801/3673/3678/3655/3679/8516/3683/3685/3687/3689/3690/3694/3717/3718/3791/284217/3909/3910/3911/3913/3915/3918/10319/23566/4843/4846/5008/9180/5155/5159/5209/5210/5228/23035/5293/23533/10891/5522/5523/5618/6513/6514/6515/6696/7010/7058/3371/7424/7450	96
WP453	Inflammatory response pathway	17/1472	26/5963	1.29625638649243e-05	0.000351285480739449	0.000287905365842003	940/958/941/942/1277/1278/1281/3458/3559/3560/3568/3911/3913/3915/3918/7133/7535	17
WP129	Matrix metalloproteinases	16/1472	24/5963	1.63049929122601e-05	0.000420824102783094	0.000344897594434775	4312/4319/4321/4322/4323/4327/4313/10893/64386/79148/4314/4316/4318/7076/7078/7124	16
WP4493	Cells and molecules involved in local acute inflammatory response 	12/1472	16/5963	3.23473600562857e-05	0.00079692132502304	0.000653138083433138	718/729/3383/3552/3569/3683/3689/3827/6403/6404/7124/7412	12
WP5063	FOXP3 in COVID-19	11/1472	14/5963	3.42237715553318e-05	0.000806490616651733	0.000660980851091535	940/941/942/50943/3559/3560/3569/3572/3575/6774/6776	11
WP2882	Nuclear receptors meta-pathway	95/1472	268/5963	3.66448482208927e-05	0.000827562822321826	0.00067825113812354	5243/1244/64240/64241/51/177/51129/335/345/8553/330/874/6347/6364/983/8824/23491/1545/1557/1559/1576/1551/66002/1907/54566/1969/2168/9982/2289/2938/2939/2947/2949/1839/3082/3458/3589/3553/117283/3726/23764/4199/4240/4791/1728/8431/9971/9970/3084/5105/5142/5155/5166/5460/10891/9588/22949/5743/6286/6319/6397/5272/1836/6513/6514/6515/11182/29986/55630/283375/115584/159963/6527/200010/11254/340024/6532/6533/23657/8140/5552/27286/6774/2040/6817/6822/7042/7056/7124/7128/84951/1831/54657/54578/7364	95
WP5088	Prostaglandin signaling	17/1472	28/5963	5.2939344474583e-05	0.00114772498820896	0.000940648562874696	834/6347/6348/729230/940/2919/3627/4283/3458/3605/3552/3553/3569/4318/114548/9536/7124	17
WP530	Cytokines and inflammatory response	13/1472	19/5963	7.03596414516747e-05	0.00146672791026183	0.0012020958984861	1437/1440/2919/2920/3122/3123/3458/3586/3589/3552/3553/3569/7124	13
WP4172	PI3K-Akt signaling pathway	97/1472	280/5963	8.45004639765976e-05	0.00169626857315985	0.0013902220584064	10000/285/672/898/1101/1277/1278/1280/1282/1284/1286/1291/1292/1293/256076/131873/1297/64764/84699/9586/1440/1441/54541/1942/1946/1969/2149/2246/2255/2259/2247/2252/2254/2261/2321/2324/2690/2784/59345/10681/51764/2786/3082/7184/3455/3559/3560/3563/3569/3575/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/3717/3718/3791/284217/3909/3910/3911/3913/3915/3918/10319/23566/4846/5008/9180/5105/5155/5159/5228/23035/118788/5293/8503/23533/29941/5522/5523/5618/10110/6696/7010/7058/7097/7099/3371/7424/7450	97
WP4494	Selective expression of chemokine receptors during T-cell polarization	15/1472	24/5963	9.22598560172754e-05	0.00178588721290583	0.00146367139997332	6348/6351/1230/729230/1232/1233/940/1437/2833/3458/3594/3595/8809/7042/7043	15
WP2849	Hematopoietic stem cell differentiation	23/1472	46/5963	0.000174259353519045	0.00320288690501896	0.00262501121366867	91/947/4261/1437/1440/10320/3552/3553/3569/3690/51176/4005/4582/3071/4778/399/23541/6688/6776/7068/7173/23650/7409	23
WP4969	RAS and bradykinin pathways in COVID-19	15/1472	25/5963	0.000178241426088839	0.00320288690501896	0.00262501121366867	1636/59272/183/185/1576/3552/3553/3816/3818/3827/4846/4881/5054/710/7124	15
WP4538	Regulatory circuits of the STAT3 signaling pathway	33/1472	75/5963	0.000183190948442044	0.00320288690501896	0.00262501121366867	185/1271/1438/1439/1441/1844/2149/2151/9002/2690/3455/3587/3595/3601/50615/9466/3559/3560/3563/3568/3572/3575/3717/3718/5600/6300/9180/5159/5579/5788/80854/9021/6774	33
WP5033	Genes associated with the development of rheumatoid arthritis	12/1472	18/5963	0.000198311700857319	0.00325711945044445	0.00266945893976997	958/4261/1493/3123/3559/3572/3685/23569/26147/6583/6775/7185	12
WP545	Complement activation	12/1472	18/5963	0.000198311700857319	0.00325711945044445	0.00266945893976997	715/716/717/718/720/721/729/1604/629/1675/5199/5648	12
WP3617	Photodynamic therapy-induced NF-kB survival signaling	18/1472	33/5963	0.00021851294745372	0.00348335345646813	0.00285487504103622	597/330/332/1437/2920/3383/3552/3553/3569/4312/4313/4314/4318/4791/5743/6401/7124/7412	18
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	16/1472	28/5963	0.000239348279704207	0.00370647907427658	0.00303774358000528	6347/29126/941/942/1493/3627/3559/3560/4791/5133/8651/6774/7042/7043/7099/51311	16
WP3937	Microglia pathogen phagocytosis pathway	20/1472	39/5963	0.000297707177226307	0.00448214694601829	0.00367346283010238	10095/1536/2207/2209/3055/3684/3689/4067/653361/4688/4689/3071/5293/8503/5336/5880/27036/54210/7409/10451	20
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	22/1472	45/5963	0.000362071322636067	0.00530385559104725	0.00434691602140598	2180/2182/9023/1593/1718/1717/54898/60481/3992/9415/2222/2224/3157/3158/51478/3422/4047/6307/4597/6319/8435/6713	22
WP1604	Codeine and morphine metabolism	8/1472	10/5963	0.000373899741994708	0.00533299105687189	0.00437079476791598	5243/1244/1558/1565/1576/54575/54578/7364	8
WP117	GPCRs, other	19/1472	37/5963	0.000411382154131234	0.00547446892462029	0.00448674672011995	27202/1131/3577/3579/2833/1909/2149/29933/4935/11245/1880/53831/59340/3363/59352/53829/5737/1901/6752	19
WP1533	Vitamin B12 metabolism	19/1472	37/5963	0.000411382154131234	0.00547446892462029	0.00448674672011995	335/338/875/6347/8029/2155/3383/3458/3553/3569/3949/4791/6288/6289/5054/6648/6947/6948/7124	19
WP702	Metapathway biotransformation Phase I and II	48/1472	125/5963	0.000414120343006332	0.00547446892462029	0.00448674672011995	50515/166012/9435/9469/1545/56603/1593/1594/1557/1558/1559/1565/1573/29785/54905/1576/1551/66002/8529/260293/9420/2052/2053/2326/2327/2328/2330/9514/79690/92292/2938/2939/2947/2949/9955/90161/8514/9027/339983/4837/6817/6799/6822/54575/54657/54578/79799/7364	48
WP474	Endochondral ossification	26/1472	57/5963	0.000438722039442736	0.00552993826460379	0.0045322080941208	9510/9507/11096/249/50515/1280/4921/5167/2247/2261/2487/2690/3157/3549/4256/4322/4318/5328/5745/5744/864/55553/6696/6772/7042/7078	26
WP4808	Endochondral ossification with skeletal dysplasias	26/1472	57/5963	0.000438722039442736	0.00552993826460379	0.0045322080941208	9510/9507/11096/249/50515/1280/4921/5167/2247/2261/2487/2690/3157/3549/4256/4322/4318/5328/5745/5744/864/55553/6696/6772/7042/7078	26
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	18/1472	35/5963	0.000568952124372936	0.00700845571386661	0.00574396642309519	285/597/332/664/1906/3091/3485/3486/3939/4843/5315/5366/5743/5054/6566/6513/6515/7043	18
WP3945	TYROBP causal network in microglia	27/1472	61/5963	0.00061746529468851	0.00743702643824828	0.00609521296745149	54518/718/8832/64764/79690/202309/3059/3142/10261/3587/3606/3684/3687/3689/4688/3071/375387/5341/170954/5996/864/64092/6696/6776/10312/113277/7133	27
WP24	Peptide GPCRs	20/1472	41/5963	0.000690370051080767	0.00760810123241476	0.00623542186847743	185/728/1230/729230/1232/1233/1237/10803/3577/3579/2833/10663/1909/2357/2358/5540/6751/6752/6869/7253	20
WP4754	IL-18 signaling pathway	81/1472	239/5963	0.000699542727533486	0.00760810123241476	0.00623542186847743	35/11096/321/467/330/841/6362/6363/6347/6364/6348/6351/890/9308/1051/1071/9076/24146/6900/1277/1278/1281/2920/2921/1674/1891/2023/338442/3315/26353/3383/8870/3458/3586/3606/8809/8807/3553/3559/3569/3659/3801/10365/4312/4322/4323/4313/4314/4318/653361/4688/4791/64332/4843/8431/3164/7941/5579/5743/5778/5806/6004/8698/9021/6696/341359/6869/30009/7052/7076/7078/55858/7124/7127/7128/4982/79931/7185/10194/80149/51222	81
WP272	Blood clotting cascade	10/1472	15/5963	0.000701854357233834	0.00760810123241476	0.00623542186847743	2159/2160/2152/2155/3816/3818/5328/5054/5345/7450	10
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	10/1472	15/5963	0.000701854357233834	0.00760810123241476	0.00623542186847743	302/335/338/1071/3949/3990/9388/4023/4547/255738	10
WP5109	Familial hyperlipidemia type 2	10/1472	15/5963	0.000701854357233834	0.00760810123241476	0.00623542186847743	335/337/338/1071/2053/2690/3949/3990/4023/255738	10
WP3529	Zinc homeostasis	17/1472	33/5963	0.000787643706856882	0.00837064488463589	0.00686038481514147	4489/4493/4494/4495/4496/4500/4499/4501/4502/4504/55532/7780/7782/169026/29986/55630/283375	17
WP3929	Chemokine signaling pathway	55/1472	152/5963	0.000905253967540931	0.0094355317385997	0.00773314118020795	196883/10000/6356/6361/6363/6364/6367/6369/6370/10344/6348/6351/1230/729230/1232/1233/1237/10803/6376/3627/6373/2921/6374/4283/3579/2833/10663/1794/9844/2268/2784/59345/10681/51764/2786/2869/3055/3702/3717/3718/4067/653361/5196/5293/8503/23533/23236/5579/5880/25759/6772/6774/7409/10451/7454	55
WP5097	CCL18 signaling pathway	19/1472	39/5963	0.000954408911974048	0.00976018170358366	0.00799921670015985	467/1237/960/1278/1437/3091/3939/440823/4313/4318/6513/6615/6772/7004/7020/7291/7412/7424/7431	19
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	27/1472	63/5963	0.00113092088864725	0.0113510948453113	0.00930309191050956	59272/841/6347/6348/6351/11126/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/3433/8519/3455/3586/3569/3902/5196/6772/7020/7124	27
WP2431	Spinal cord injury	38/1472	98/5963	0.0012951635947709	0.0127632485157423	0.0104604600381497	301/63827/6347/729230/983/50515/1280/1282/1464/2919/3627/2920/2212/2697/3383/3458/3552/3553/3554/3569/10288/11025/1241/4321/4318/4843/3164/5320/5362/5743/6098/6403/57556/6869/7099/7124/10673/7431	38
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	18/1472	37/5963	0.00132064062748321	0.0127819146445696	0.0104757583608631	9744/9447/84674/834/838/841/50506/3606/3553/4210/58484/22861/91662/114548/199713/64127/639/8767	18
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	47/1472	128/5963	0.00146519495480155	0.0139322046579376	0.0114185091583796	116/8553/720/721/1051/1103/1139/1141/1390/1644/54738/2328/2305/2697/2784/3091/7184/3359/3586/3552/3553/3557/3569/3764/4128/4760/4791/4821/4824/5354/5452/5460/10891/5577/864/6507/6532/6616/6750/6751/6752/6869/7068/7124/7161/7166/7433	47
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	13/1472	24/5963	0.00181153628840213	0.0169284942812751	0.0138741980708838	51/8309/246/240/66002/8529/10800/57105/1800/2358/1241/22949/8989	13
WP4210	Tryptophan catabolism leading to NAD+ production	9/1472	14/5963	0.00193291966794285	0.0175082948734694	0.014349389078664	23498/3620/8564/8942/10135/23057/349565/23475/6999	9
WP43	Oxidation by cytochrome P450	18/1472	38/5963	0.00193818762436931	0.0175082948734694	0.014349389078664	51700/1545/56603/1593/1594/1557/1558/1559/1565/1573/29785/54905/1576/1551/66002/8529/260293/9420	18
WP3892	Development of pulmonary dendritic cells and macrophage subsets	8/1472	12/5963	0.00252394975668127	0.0224259142314958	0.0183797549149179	55509/1437/10320/3662/6688/6774/6925/7173	8
WP430	Statin inhibition of cholesterol production	13/1472	25/5963	0.00293031184743213	0.0256165971178744	0.0209947640002777	64240/64241/335/337/338/345/1071/2222/3949/3990/4023/4547/6713	13
WP5094	Orexin receptor pathway	41/1472	112/5963	0.00305080496210762	0.0262466077692433	0.0215111059984865	8553/2920/1734/1846/1959/1960/2324/84264/1839/3091/8091/9456/3309/3383/3586/3553/3569/3726/3777/3939/3949/4023/84230/23764/7873/4322/4314/4846/3164/8013/26031/5069/5163/6241/6401/6498/6513/6696/3371/7124/7412	41
WP197	Cholesterol biosynthesis pathway	9/1472	15/5963	0.00377951763400637	0.0320077899629915	0.0262328362097153	1717/2222/2224/3157/3422/4047/6307/4597/6713	9
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	27/1472	68/5963	0.00423737290064754	0.0353331709561687	0.028958240713737	816/857/6347/958/1594/1673/2113/10964/3458/3569/9636/5600/6300/4791/64127/4939/23236/5333/5336/5579/91543/6258/6772/7097/7099/51311/7124	27
WP2880	Glucocorticoid receptor pathway	26/1472	65/5963	0.00441438190275449	0.0362514392620141	0.0297108319451737	51129/8553/330/6347/6364/1907/54566/9982/3589/4240/8972/4791/9970/5142/5460/5743/6286/6397/5272/1836/5552/2040/7056/7128/84951/1831	26
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	13/1472	26/5963	0.00455316975377698	0.0368331045753302	0.0301875512347822	51/8309/66002/8529/5729/5730/9536/5737/5739/5740/22949/5743/6916	13
WP15	Selenium micronutrient network	24/1472	59/5963	0.00475525491874327	0.0379021789111596	0.031063739562069	240/335/338/875/6347/1734/1735/2155/3383/3458/3553/3569/8564/8942/3949/4791/10549/5743/6288/6289/5054/6648/7124/7498	24
WP5193	Cholesterol synthesis disorders	10/1472	18/5963	0.00485489067714718	0.0381355180726634	0.0312549788826256	1718/1717/2222/2224/3157/3422/4047/6307/4597/6713	10
WP4724	Omega-9 fatty acid synthesis	8/1472	13/5963	0.00514878948647678	0.0398663414524345	0.0326735212525293	2180/2182/54898/60481/79071/3992/9415/6319	8
WP3942	PPAR signaling pathway	22/1472	54/5963	0.00658610836800244	0.049536095294358	0.0405986253917636	51/8309/2180/2182/51129/335/345/364/126129/1593/2168/2172/9415/3158/4023/4199/4312/4973/5105/6258/6319/28965	22
WP247	Small ligand GPCRs	9/1472	16/5963	0.00676323072284593	0.049536095294358	0.0405986253917636	4543/5724/5729/5737/5739/1901/9294/1903/8698	9
WP4478	LTF danger signal response pathway	9/1472	16/5963	0.00676323072284593	0.049536095294358	0.0405986253917636	177/3552/3553/3569/4057/7097/7099/7124/54210	9
WP516	Hypertrophy model	9/1472	16/5963	0.00676323072284593	0.049536095294358	0.0405986253917636	467/11072/1839/3458/3606/3552/3554/8013/6935	9
WP229	Irinotecan pathway	7/1472	11/5963	0.00696661791140628	0.0503454254397627	0.0412619334542238	4363/1244/9429/590/8824/1576/54575	7
WP465	Tryptophan metabolism	15/1472	33/5963	0.00731135788205866	0.0519038824928174	0.0425392084132238	8854/316/1545/1573/1576/66002/9420/1644/1718/23498/3620/8942/4129/6999/7166	15
WP4329	miRNAs involvement in the immune response in sepsis	17/1472	39/5963	0.00737379880433015	0.0519038824928174	0.0425392084132238	6348/6351/3002/3383/3586/3552/3569/3659/3934/114614/407008/407024/4791/7099/51311/7124/7412	17
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	11/1472	22/5963	0.00891386049575677	0.0619399024192329	0.0507644956708415	2919/2920/2247/3553/4821/5155/5354/6469/6663/55553/7124	11
WP697	Estrogen metabolism	8/1472	14/5963	0.00943661591118872	0.064570323334406	0.0529203271453085	1545/1576/2938/1728/412/6817/54578/7364	8
WP5092	Interactions of natural killer cells in pancreatic cancer	12/1472	25/5963	0.00953067503090863	0.064570323334406	0.0529203271453085	6347/6348/6351/10666/1437/2214/3002/3458/4277/5551/201633/7124	12
WP2848	Pluripotent stem cell differentiation pathway	15/1472	34/5963	0.0101545715052323	0.0679478735288385	0.0556884883067971	3577/22943/2246/2255/2247/3082/3589/3569/3624/5155/6469/7043/7173/7472/7474	15
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	9/1472	17/5963	0.0112626319302973	0.0744432500758673	0.0610119470421752	249/1594/5167/56975/2261/4791/6098/142680/6696	9
WP167	Eicosanoid synthesis	10/1472	20/5963	0.0125269316692424	0.0808285352943977	0.0662451774990014	246/240/1800/5320/80339/5730/9536/5740/5743/6916	10
WP5044	Kynurenine pathway and links to cell senescence	10/1472	20/5963	0.0125269316692424	0.0808285352943977	0.0662451774990014	23498/3620/169355/3458/8564/8942/23475/6999/7099/7124	10
WP98	Prostaglandin synthesis and regulation	17/1472	41/5963	0.013153858506297	0.0821494655607764	0.0673277810577736	301/302/306/307/308/1906/1909/3290/10891/5729/5730/9536/5737/5739/5740/5743/6916	17
WP4495	IL-10 anti-inflammatory signaling pathway 	7/1472	12/5963	0.0131863533280213	0.0821494655607764	0.0673277810577736	644/3586/3587/3552/3569/6772/6774	7
WP5110	Familial hyperlipidemia type 3	7/1472	12/5963	0.0131863533280213	0.0821494655607764	0.0673277810577736	335/337/1071/3949/3990/4023/7436	7
WP4545	Oxysterols derived from cholesterol	14/1472	32/5963	0.0139693966841324	0.0851701313600395	0.0698034481140739	134526/23597/8309/23600/9023/1593/1576/9420/1717/2053/1880/3605/3638/6097	14
WP2876	Pregnane X receptor pathway	13/1472	29/5963	0.013985501274988	0.0851701313600395	0.0698034481140739	5243/1244/1557/1559/1576/1551/66002/2939/10891/27286/6822/54657/54578	13
WP5174	Ulcerative colitis signaling	8/1472	15/5963	0.0159018710851113	0.0957646014236704	0.0784864280458126	50943/3108/3458/3586/4772/64127/7097/7124	8
WP497	Urea cycle and metabolism of amino groups	9/1472	18/5963	0.0176703731834474	0.10438802305052	0.0855539827681477	445/1152/2628/162417/4942/4953/5009/5831/6723	9
WP306	Focal adhesion	58/1472	183/5963	0.0177190002225974	0.10438802305052	0.0855539827681477	10000/330/857/1101/1277/1278/1280/1282/1284/1286/1290/50509/1292/2268/2316/2318/2321/2534/3055/3082/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/3791/284217/3909/3910/3911/3913/3915/3918/10319/29780/64098/5155/5159/5228/5293/8503/5579/5880/25759/6696/10420/7058/3371/7409/10451/7424/7450/7791	58
WP2884	NRF2 pathway	39/1472	116/5963	0.0182079540153421	0.106115172863606	0.0869695143686966	1244/177/874/8824/23491/1969/2938/2939/2947/2949/1839/3082/23764/4199/1728/3084/5155/9588/22949/6513/6514/6515/11182/29986/55630/283375/115584/159963/6527/200010/11254/340024/6532/6533/23657/7042/54657/54578/7364	39
WP2875	Constitutive androstane receptor pathway	12/1472	27/5963	0.019373677044659	0.110531925875844	0.0905893818597906	5243/1244/1557/1559/1576/2939/9970/10891/6817/6822/54657/54578	12
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	12/1472	27/5963	0.019373677044659	0.110531925875844	0.0905893818597906	59272/6347/2939/2977/3553/3569/4312/4314/1728/5593/23657/7124	12
WP2289	Drug induction of bile acid pathway	7/1472	13/5963	0.0225635111431565	0.124790031016233	0.102274991432997	5243/1244/1576/9971/9970/123264/6822	7
WP4723	Omega-3 / omega-6 fatty acid synthesis	7/1472	13/5963	0.0225635111431565	0.124790031016233	0.102274991432997	51/2180/2182/54898/60481/3992/9415	7
WP5108	Familial  hyperlipidemia type 1	7/1472	13/5963	0.0225635111431565	0.124790031016233	0.102274991432997	51129/335/337/1071/3949/3990/4023	7
WP716	Vitamin A and carotenoid metabolism	14/1472	34/5963	0.024979843966697	0.13675833767626	0.112083935714472	64240/64241/8854/1381/1382/56603/4023/9227/29881/5915/5948/6258/195814/6817	14
WP4541	Hippo-Merlin signaling dysregulation	34/1472	101/5963	0.0257564122536265	0.139599754414656	0.114412694431899	84962/960/1009/1014/1001/1003/1004/3627/1969/2261/2321/2324/2305/3672/22801/3673/3678/3655/3679/8516/3683/3684/3685/3687/3689/3690/3694/3791/26524/5159/5577/6788/7004/7010	34
WP3613	Photodynamic therapy-induced unfolded protein response	11/1472	25/5963	0.026870907553999	0.144198335586807	0.118181584031137	440/467/811/51726/4189/9695/121506/7184/3309/57761/7494	11
WP5098	T-cell activation SARS-CoV-2	28/1472	81/5963	0.0288078118034867	0.153076803896959	0.125458169051304	84433/6363/940/915/941/942/1029/1493/2534/3122/3123/29851/3455/3458/3594/3595/3605/8809/51561/3717/3937/4049/4772/5293/10125/6775/7124/7535	28
WP2858	Ectoderm differentiation	39/1472	120/5963	0.03141317218035	0.16530038176456	0.135476327645454	398/170302/91653/6347/1004/5010/1496/1896/54898/2274/2534/2627/57476/9687/152789/3801/3853/9079/4061/4772/22871/5080/345557/5362/5420/5452/5783/114822/6386/5269/6469/6498/7903/6781/7020/4982/54521/7704/51222	39
WP4583	Biomarkers for urea cycle disorders	6/1472	11/5963	0.0322189134091502	0.16631096255009	0.13630457602668	445/2159/2155/2628/162417/5009	6
WP4707	Aspirin and miRNAs	6/1472	11/5963	0.0322189134091502	0.16631096255009	0.13630457602668	283120/114614/4597/4846/5163/5743	6
WP176	Folate metabolism	18/1472	48/5963	0.0326699431163564	0.167048199708162	0.136908798362486	335/338/875/6347/2155/3383/3458/3553/3569/3949/10797/4791/6288/6289/5054/113235/6648/7124	18
WP2879	Farnesoid X receptor pathway	7/1472	14/5963	0.0356904063751245	0.175894876417306	0.144159327729856	1576/2289/117283/8431/9971/10891/6822	7
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	7/1472	14/5963	0.0356904063751245	0.175894876417306	0.144159327729856	3589/3569/3572/3717/3718/6774/6935	7
WP4582	Cancer immunotherapy by CTLA4 blockade	7/1472	14/5963	0.0356904063751245	0.175894876417306	0.144159327729856	940/941/942/1493/3123/5293/8503	7
WP5130	Th17 cell differentiation pathway	22/1472	62/5963	0.036896648542679	0.175894876417306	0.144159327729856	915/50943/3091/3108/3458/3605/3553/50615/51561/9466/3559/3569/3662/3717/4772/6097/9021/6772/6774/6776/30009/7535	22
WP3287	Overview of nanoparticle effects	8/1472	17/5963	0.0372875154625586	0.175894876417306	0.144159327729856	10000/1001/1282/3569/3909/5293/5743/7124	8
WP3967	miR-509-3p alteration of YAP1/ECM axis	8/1472	17/5963	0.0372875154625586	0.175894876417306	0.144159327729856	1277/1281/1289/1909/6678/7004/7058/7291	8
WP3893	Development and heterogeneity of the ILC family	10/1472	23/5963	0.0373208686125279	0.175894876417306	0.144159327729856	3458/3605/3606/3553/51561/90865/3569/30009/7124/7704	10
WP4197	Immune response to tuberculosis	10/1472	23/5963	0.0373208686125279	0.175894876417306	0.144159327729856	3437/8519/3455/3659/10379/3717/5696/8651/6772/6890	10
WP4585	Cancer immunotherapy by PD-1 blockade	10/1472	23/5963	0.0373208686125279	0.175894876417306	0.144159327729856	10538/29126/915/3123/3458/4772/5133/80380/6774/7535	10
WP534	Glycolysis and gluconeogenesis	15/1472	39/5963	0.0390918505001557	0.182653301474865	0.149698374873554	229/230/2023/2026/2203/3099/3101/3939/5105/5214/5313/5315/6513/6514/6515	15
WP5087	Malignant pleural mesothelioma	109/1472	381/5963	0.0394986242085118	0.182976532658234	0.14996328759327	72/9510/177/84962/10000/285/467/672/834/6347/6351/898/29126/960/1009/1014/1001/1003/1004/1029/1282/1284/1286/1437/1440/115908/1496/2919/3627/6374/80319/22943/1942/1946/1969/2246/2255/2259/2247/2252/2254/2261/2321/2324/8061/2305/11211/1839/3082/3091/3620/3586/3553/3569/3672/3673/3655/3685/3689/3690/3791/9493/284217/3909/3910/3911/3913/3915/3918/10319/26524/51176/9064/11184/9448/4323/4313/4314/4318/114548/5155/5159/5163/5228/5293/5328/5420/10891/9770/83593/6401/5176/6423/6425/6513/8140/64321/6678/6772/6788/7004/7010/7015/29128/7424/7480/7481/7472/7474	109
WP5083	Neuroinflammation and glutamatergic signaling	37/1472	115/5963	0.0409963682403839	0.18830535242617	0.154330663670312	816/27185/2247/2892/2893/2898/2906/116443/3458/3586/3587/3552/3553/3554/3569/3572/84230/80131/4049/4791/26227/23236/5579/29968/6505/6507/6509/6513/6515/92745/9021/6772/6774/7042/7043/7124/7133	37
WP75	Toll-like receptor signaling pathway	28/1472	84/5963	0.0455500193868836	0.207463113510008	0.170031916685227	10000/841/6348/6351/958/941/942/3627/6373/4283/3455/3553/3569/23643/1326/5600/6300/5293/8503/23533/6696/6772/7096/7097/7099/51311/54106/7124	28
WP5122	Prostaglandin and leukotriene metabolism in senescence 	11/1472	27/5963	0.0482040803218228	0.2177217627869	0.178439665752712	246/240/10800/3488/5600/23236/5730/9536/5740/5743/6916	11
WP2881	Estrogen receptor pathway	6/1472	12/5963	0.0512514734902791	0.225839826274238	0.185093040760785	51/1545/8431/5105/5166/6774	6
WP5112	Familial hyperlipidemia type 5	6/1472	12/5963	0.0512514734902791	0.225839826274238	0.185093040760785	335/337/1071/3949/3990/4023	6
WP5188	Retinol Metabolism	6/1472	12/5963	0.0512514734902791	0.225839826274238	0.185093040760785	316/54905/1551/10170/9227/195814	6
WP727	Monoamine transport	9/1472	21/5963	0.0519145118882667	0.22691665680194	0.185975585881567	183/273/3553/3554/3690/6532/6999/7124/4982	9
WP2855	Dopaminergic neurogenesis	7/1472	15/5963	0.0530053747538859	0.229831304932849	0.188364363335915	1644/4009/4760/4821/4929/6469/6774	7
WP2406	Cardiac progenitor differentiation	12/1472	31/5963	0.0587287538967203	0.252626862000178	0.207047068875656	290/22943/2247/3624/3670/3791/83881/3084/5080/5460/64321/7070	12
WP236	Adipogenesis	36/1472	115/5963	0.0628092237058321	0.268051962587094	0.21968912062877	183/651/1051/1675/1271/56603/1879/1959/2487/3091/3569/3572/8609/23175/4023/83881/10135/7025/5008/5105/80339/10891/5618/5740/6258/6319/5054/8651/9021/6772/6774/6776/7124/57761/7291/7480	36
WP3591	Sleep regulation	9/1472	22/5963	0.0692365868835049	0.289891691609489	0.237588451853184	100/134/1141/51738/3606/3569/22871/5729/5730	9
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	18/1472	52/5963	0.0695312175447115	0.289891691609489	0.237588451853184	308/602/332/79092/2113/2149/3309/3315/8870/3575/1728/3084/8767/9021/7124/7185/10451/7431	18
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	18/1472	52/5963	0.0695312175447115	0.289891691609489	0.237588451853184	10000/898/1003/1277/1278/2321/3082/3791/4313/4318/4791/5361/5362/91584/55630/6615/7042/7043	18
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	5/1472	10/5963	0.074338934826841	0.306951943968309	0.2515706357635	1116/3572/4318/9021/6774	5
WP3413	NOTCH1 regulation of endothelial cell calcification	7/1472	16/5963	0.0747558239922818	0.306951943968309	0.2515706357635	249/813/2261/2702/3672/4256/55553	7
WP554	ACE inhibitor pathway	6/1472	13/5963	0.0758411555020984	0.309066964527348	0.25330405715778	1636/59272/183/185/3827/4846	6
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	8/1472	20/5963	0.0954371831438664	0.3860220392834	0.316374636973383	332/3315/3569/3791/4318/6696/6774/7099	8
WP5111	Familial hyperlipidemia type 4	7/1472	17/5963	0.100983639963088	0.402661878534923	0.330012260131555	335/337/1071/3949/3990/4023/4547	7
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	21/1472	65/5963	0.101036928931272	0.402661878534923	0.330012260131555	947/22943/147409/1959/94234/2619/3458/3488/26085/5653/5650/51176/4488/4772/22822/864/25928/6925/8626/7474/7704	21
WP2197	Endothelin pathways	10/1472	27/5963	0.105304611476502	0.416139027552553	0.341057816327786	10203/1906/1909/2769/10681/51764/4846/4852/23236/5739	10
WP12	Osteoclast signaling	6/1472	14/5963	0.105954217347329	0.416139027552553	0.341057816327786	1513/8111/3690/5155/6696/4982	6
WP5052	Nephrogenesis	5/1472	11/5963	0.109438952674916	0.42609545482017	0.349217871303383	8854/80000/130497/284654/84870	5
WP4008	NO/cGMP/PKG mediated neuroprotection	12/1472	34/5963	0.110061556595616	0.42609545482017	0.349217871303383	816/1259/1261/2906/2977/3458/3553/4843/4846/4881/5593/7124	12
WP3646	Hepatitis C and hepatocellular carcinoma	16/1472	48/5963	0.111941208214335	0.430298828738792	0.352662858278831	330/332/672/960/1284/3577/2487/3091/3569/51176/4312/4843/5420/5743/6241/6774	16
WP1539	Angiogenesis	9/1472	24/5963	0.113465186623944	0.433085430635053	0.35494669203339	2247/2321/3091/3791/4318/4846/5155/7010/7078	9
WP3925	Amino acid metabolism	24/1472	77/5963	0.117516841893455	0.445413484659109	0.365050476842385	126/440/445/586/875/1644/84706/3034/3067/3158/3939/4128/4357/4942/4953/5009/5105/5166/5315/5831/6723/6999/7166/7173	24
WP4496	Signal transduction through IL1R	11/1472	31/5963	0.119184540826272	0.448597368943329	0.367659913952388	3552/3553/3554/3556/3557/3569/3656/11213/7042/7043/7124	11
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	8/1472	21/5963	0.122220365455005	0.456851297080087	0.374424640450178	941/942/3101/3122/3586/3939/5210/6515	8
WP3877	MYD88 distinct input-output pathway	7/1472	18/5963	0.131530628575878	0.485256385284664	0.397704786541325	3552/92610/7096/7097/7099/51311/54106	7
WP4136	Fibrin complement receptor 3 signaling pathway	12/1472	35/5963	0.131610126636246	0.485256385284664	0.397704786541325	6347/3627/2921/3569/3656/3684/3689/23643/4843/83593/7099/7124	12
WP4900	Purinergic signaling	9/1472	25/5963	0.140270712674027	0.512245398230545	0.419824350462789	134/5027/27334/53829/9934/5030/5031/286530/24145	9
WP4747	Netrin-UNC5B signaling pathway	15/1472	46/5963	0.140820229402862	0.512245398230545	0.419824350462789	249/6347/1003/1277/2534/3383/3586/3552/3635/3791/59277/54538/6401/7124/7412	15
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	5/1472	12/5963	0.1510014378068	0.545618528608572	0.447176187750665	2222/2224/3157/3422/4597	5
WP4595	Urea cycle and associated pathways	8/1472	22/5963	0.152496810353005	0.547372657028666	0.448613830386671	8659/445/162417/4843/4846/4942/5009/5831	8
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	20/1472	65/5963	0.158641025755478	0.565680499733351	0.463618510171828	816/941/9076/1286/1378/1514/22943/1759/2534/3685/3690/3911/3913/4288/4311/4868/5329/5420/7099/7431	20
WP286	IL-3 signaling pathway	15/1472	47/5963	0.162029041070783	0.573985230459899	0.470424873284283	1232/969/942/1439/2534/3055/3563/3568/3635/3717/4067/5293/6774/6776/7409	15
WP4746	Thyroid hormones production and peripheral downstream signaling effects	24/1472	80/5963	0.163335994321754	0.574857850145394	0.471140051973891	10000/364/1734/1735/50506/405753/3685/3690/389434/152831/57224/4881/4852/23236/10891/5593/27330/6469/6567/5172/7038/7068/7173/7253	24
WP299	Nuclear receptors in lipid metabolism and toxicity	9/1472	26/5963	0.169978360593242	0.586804276697689	0.480931063830695	5243/1244/64240/1594/1559/1576/9971/9970/5915	9
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	9/1472	26/5963	0.169978360593242	0.586804276697689	0.480931063830695	2254/2261/3549/5600/6300/5745/5744/6615/6772	9
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	9/1472	26/5963	0.169978360593242	0.586804276697689	0.480931063830695	1390/2555/2557/2562/2564/2568/3717/8503/6774	9
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	6/1472	16/5963	0.181152018793363	0.621420216367106	0.509301478552959	2534/3122/3123/3569/64386/7535	6
WP4239	Epithelial to mesenchymal transition in colorectal cancer	38/1472	134/5963	0.184239724304755	0.62602592635507	0.513076210762943	10000/8999/9076/5010/24146/51208/9075/137075/9073/1282/1284/1286/56648/2305/94234/11211/3091/3678/26524/5600/6300/4313/4318/4854/4855/8828/5293/8503/6615/6678/7042/7043/7291/7480/7481/7472/7474/6935	38
WP2361	Gastric cancer network 1	8/1472	23/5963	0.185959730891451	0.62602592635507	0.513076210762943	6790/144455/1894/11082/4605/6286/22974/11065	8
WP5064	7-oxo-C and 7-beta-HC pathways	8/1472	23/5963	0.185959730891451	0.62602592635507	0.513076210762943	134526/23597/8309/23600/1593/1717/2053/3290	8
WP1434	Osteopontin signaling	5/1472	13/5963	0.197976614247239	0.654288566597583	0.536239609835269	3685/3690/4318/5328/6696	5
WP5176	Disorders of bile acid synthesis and biliary transport	5/1472	13/5963	0.197976614247239	0.654288566597583	0.536239609835269	1244/8309/23600/1593/9420	5
WP5178	Disorders of fructose metabolism	5/1472	13/5963	0.197976614247239	0.654288566597583	0.536239609835269	229/2203/3795/6514/6652	5
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	14/1472	45/5963	0.200696194638904	0.65925659087446	0.540311286364386	695/6356/2534/3055/3559/3569/3575/3717/4067/4791/6772/6774/6775/6776	14
WP2374	Oncostatin M signaling pathway	19/1472	64/5963	0.212875302737939	0.68463945651789	0.561114489513594	6347/1051/3091/3572/3717/3718/3726/3949/4312/4322/4314/5008/9180/5579/5054/9021/6772/6774/7078	19
WP4298	Acute viral myocarditis	23/1472	79/5963	0.213073445356559	0.68463945651789	0.561114489513594	834/841/857/1232/1604/941/1906/2534/3108/3458/3586/3569/3683/3689/4318/4791/64127/5880/8651/6772/6774/7099/7124	23
WP1423	Ganglio sphingolipid metabolism	4/1472	10/5963	0.216675723825202	0.68463945651789	0.561114489513594	6482/6483/8869/6489	4
WP2436	Dopamine metabolism	4/1472	10/5963	0.216675723825202	0.68463945651789	0.561114489513594	1644/4128/4129/1728	4
WP4389	Bile acids synthesis and enterohepatic circulation 	4/1472	10/5963	0.216675723825202	0.68463945651789	0.561114489513594	64240/64241/3949/6555	4
WP4018	Clear cell renal cell carcinoma pathways	24/1472	83/5963	0.217593249497014	0.68463945651789	0.561114489513594	229/230/2023/2026/2321/3091/3099/3101/3791/8844/3939/4199/5155/5159/5214/26227/5313/5315/29968/6513/6774/7042/7043/6935	24
WP364	IL6 signaling pathway	13/1472	42/5963	0.218283293826311	0.68463945651789	0.561114489513594	183/3055/3569/3572/3659/3717/3726/639/9021/6772/6774/7076/7409	13
WP2064	Neural crest differentiation	20/1472	68/5963	0.218528830216965	0.68463945651789	0.561114489513594	1004/1302/1280/2113/2247/2261/51564/23493/3670/4359/4488/4791/4854/4855/283659/6615/6663/6925/7020/7291	20
WP5036	Angiotensin II receptor type 1 pathway	8/1472	24/5963	0.222207003025204	0.692162043906096	0.567279826234944	59272/183/185/1277/1278/3091/3589/3572	8
WP2324	AGE/RAGE pathway	19/1472	65/5963	0.235276417143738	0.72868467481089	0.597212920509217	177/249/841/3091/3625/3717/4322/4323/4313/4316/4318/4478/653361/4843/4846/5579/6772/6774/6776	19
WP4561	Cell migration and invasion through p75NTR	9/1472	28/5963	0.236942103123034	0.72967397666298	0.598023729174165	11093/10000/1009/1942/1946/4313/4318/6774/7291	9
WP1602	Nicotine effect on dopaminergic neurons	5/1472	14/5963	0.249100168080523	0.746217615995962	0.611582509128561	1136/1141/1644/3777/84152	5
WP3935	Leptin-insulin signaling overlap	5/1472	14/5963	0.249100168080523	0.746217615995962	0.611582509128561	3717/8503/8651/9021/6774	5
WP3971	OSX and miRNAs in tooth development	5/1472	14/5963	0.249100168080523	0.746217615995962	0.611582509128561	249/22943/407024/4854/4855	5
WP58	Monoamine GPCRs	5/1472	14/5963	0.249100168080523	0.746217615995962	0.611582509128561	147/150/1131/3274/3363	5
WP4823	Genes controlling nephrogenesis	10/1472	32/5963	0.249198133755109	0.746217615995962	0.611582509128561	2118/2296/6928/8516/3791/3913/4868/5155/5159/6469	10
WP2873	Aryl hydrocarbon receptor pathway	11/1472	36/5963	0.259577284622728	0.768802668117589	0.63009268973708	23491/1545/2939/3458/3553/3726/1728/8140/7124/54657/54578	11
WP4564	Neural crest cell migration during development	11/1472	36/5963	0.259577284622728	0.768802668117589	0.63009268973708	10000/1009/2047/2151/4313/4318/5293/8503/23533/6774/7291	11
WP4658	Small cell lung cancer	26/1472	93/5963	0.264901614556962	0.780308016792791	0.639522204479623	10000/330/841/898/1030/1282/1284/1286/3673/3655/3685/284217/3909/3910/3911/3913/3915/3918/10319/4843/5293/8503/5743/5915/6258/7185	26
WP4760	PKC-gamma calcium signaling pathway in ataxia	6/1472	18/5963	0.271555023854149	0.787847179703324	0.645701126111483	773/2769/2892/2893/5163/23236	6
WP5149	Lipid metabolism in senescent cells	6/1472	18/5963	0.271555023854149	0.787847179703324	0.645701126111483	240/84647/50487/283748/7941/5743	6
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	17/1472	59/5963	0.273126784699852	0.787847179703324	0.645701126111483	84433/940/915/1437/1493/2534/29851/3458/3586/3702/3937/1326/5133/5163/5788/7124/7535	17
WP3930	EDA signaling in hair follicle development	4/1472	11/5963	0.277953878768222	0.787847179703324	0.645701126111483	22943/1896/6469/25928	4
WP4629	Aerobic glycolysis	4/1472	11/5963	0.277953878768222	0.787847179703324	0.645701126111483	2023/3939/5315/6513	4
WP5049	Glycolysis in senescence	4/1472	11/5963	0.277953878768222	0.787847179703324	0.645701126111483	230/2023/3939/5315	4
WP5191	ResolvinE1 and ResolvinD1 signaling pathways promoting inflammation resolution	4/1472	11/5963	0.277953878768222	0.787847179703324	0.645701126111483	2358/1241/5163/5293	4
WP69	T-cell receptor signaling pathway	24/1472	86/5963	0.279089775835864	0.787847179703324	0.645701126111483	84433/940/915/9308/2534/29851/3601/3605/3552/3553/3569/3662/3702/3937/1326/11184/4772/8767/3604/7409/10451/7431/7454/7535	24
WP2118	Arrhythmogenic right ventricular cardiomyopathy	17/1472	60/5963	0.29937017979237	0.82948865077335	0.679829502090413	775/9254/785/1496/1674/2697/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/51176	17
WP241	One-carbon metabolism	8/1472	26/5963	0.301114989181386	0.82948865077335	0.679829502090413	10840/275/55349/2346/2745/25902/10797/6948	8
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	5/1472	15/5963	0.303023529249305	0.82948865077335	0.679829502090413	23086/84958/94120/94122/201294	5
WP4159	GABA receptor signaling	5/1472	15/5963	0.303023529249305	0.82948865077335	0.679829502090413	2555/2557/2562/2564/2568	5
WP4842	Mammalian disorder of sexual development	5/1472	15/5963	0.303023529249305	0.82948865077335	0.679829502090413	84733/2254/5600/5730/284654	5
WP698	Glucuronidation	5/1472	15/5963	0.303023529249305	0.82948865077335	0.679829502090413	54575/54657/54578/79799/7364	5
WP2839	Hair follicle development: organogenesis - part 2 of 3	9/1472	30/5963	0.311476326156666	0.844100843884566	0.691805313884806	1896/2246/3624/3911/51176/6469/6615/8626/7474	9
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	9/1472	30/5963	0.311476326156666	0.844100843884566	0.691805313884806	59272/3455/10379/4939/4940/6772/7097/7099/54106	9
WP5053	Development of ureteric collection system	15/1472	53/5963	0.317769329821298	0.850847380815069	0.697334617797551	653/2118/2296/80144/2719/80000/6928/8516/4613/5915/6091/6469/7042/57216/7481	15
WP1591	Heart development	10/1472	34/5963	0.319998471952217	0.850847380815069	0.697334617797551	8553/2255/2296/2627/23493/3670/4772/5308/6469/7424	10
WP3599	Transcription factor regulation in adipogenesis	6/1472	19/5963	0.320245139642572	0.850847380815069	0.697334617797551	1051/3569/23175/10891/7124/7291	6
WP5066	FOXA2 pathway	6/1472	19/5963	0.320245139642572	0.850847380815069	0.697334617797551	1244/338/2938/2939/51085/4547	6
WP289	Myometrial relaxation and contraction pathways	35/1472	131/5963	0.324181500630106	0.857104260202525	0.702462609837766	196883/133/467/800/816/1265/2697/2784/59345/10681/51764/2786/2869/2980/2981/3485/3486/3488/3553/3569/23764/4846/5142/5333/5336/5577/5579/10266/10268/5996/6004/64407/10287/5999/8490	35
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	7/1472	23/5963	0.332928192648786	0.872529314464518	0.715104623624056	185/285/2022/2200/2316/4053/5054	7
WP4917	Proximal tubule transport	12/1472	42/5963	0.333235365487371	0.872529314464518	0.715104623624056	5243/1244/9429/6560/6505/6513/6514/142680/6519/8671/340024/11136	12
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	4/1472	12/5963	0.341430099248934	0.881214827585343	0.722223067082958	8061/6776/7076/7431	4
WP4792	Purine metabolism	4/1472	12/5963	0.341430099248934	0.881214827585343	0.722223067082958	100/3614/4860/7498	4
WP5171	Metabolic pathway leukotriene 	4/1472	12/5963	0.341430099248934	0.881214827585343	0.722223067082958	4363/240/1800/22949	4
WP4816	TGF-beta receptor signaling in skeletal dysplasias	15/1472	54/5963	0.347106523280814	0.891619600086261	0.730750575328029	81794/25805/2022/2200/3458/3624/3694/51176/864/5054/6498/6696/6772/6774/7124	15
WP4241	Type 2 papillary renal cell carcinoma	9/1472	31/5963	0.350523526259241	0.896149769964665	0.734463396630585	253559/81578/1513/112399/3091/5155/6513/7042/7043	9
WP4558	Overview of interferons-mediated signaling pathway	5/1472	16/5963	0.358419670365643	0.912035029756705	0.747482584108234	3455/3458/10379/3717/6772	5
WP4565	Neural crest cell migration in cancer	11/1472	39/5963	0.362243123317631	0.91745688242129	0.751926207771964	10000/1009/2047/2151/4313/4318/5293/8503/23533/6774/7291	11
WP26	S1P receptor signal transduction	7/1472	24/5963	0.378519270729084	0.945426012604439	0.774849052862834	10000/6300/23236/1901/9294/1903/8877	7
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	7/1472	24/5963	0.378519270729084	0.945426012604439	0.774849052862834	196883/2769/4935/23236/5579/5176/7306	7
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	7/1472	24/5963	0.378519270729084	0.945426012604439	0.774849052862834	1636/59272/183/3606/3569/114548/7124	7
WP2583	T cell receptor and co-stimulatory signaling	8/1472	28/5963	0.385023998611751	0.952890444052828	0.78096672633578	940/1493/2534/3702/5133/5163/10125/7535	8
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	8/1472	28/5963	0.385023998611751	0.952890444052828	0.78096672633578	9509/1277/1278/60681/4015/5034/5176/4982	8
WP3995	Prion disease pathway	9/1472	32/5963	0.390172592891293	0.956893870348783	0.784247840915102	10538/1879/2534/7184/3309/3662/5452/6688/6774	9
WP3998	Prader-Willi and Angelman syndrome	9/1472	32/5963	0.390172592891293	0.956893870348783	0.784247840915102	57194/990/1029/1030/9638/2562/51738/4948/5122	9
WP2267	Synaptic vesicle pathway	12/1472	44/5963	0.400700207683443	0.976262960771476	0.800122294514591	773/10814/1759/26052/22999/246213/6570/6507/6532/6616/2054/6857	12
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	4/1472	13/5963	0.405187203694131	0.976262960771476	0.800122294514591	249/3655/7015/7124	4
WP5192	Modulation of the PI3K-Akt-mTOR signaling by bioactive sphingolipids	4/1472	13/5963	0.405187203694131	0.976262960771476	0.800122294514591	56624/3091/1901/1903	4
WP395	IL-4 signaling pathway	14/1472	52/5963	0.405275214342402	0.976262960771476	0.800122294514591	332/1051/9046/2316/3635/3717/3718/5600/5293/8651/9021/6772/6774/6776	14
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	5/1472	17/5963	0.414061105756303	0.988639292158221	0.810265646321167	9595/51176/3371/7412/7472	5
WP5074	Kallmann syndrome	5/1472	17/5963	0.414061105756303	0.988639292158221	0.810265646321167	23129/60675/9723/6663/26022	5
WP383	Striated muscle contraction pathway	6/1472	21/5963	0.420029566753598	0.995573047655631	0.815948390193584	1674/7134/7125/7169/7171/7431	6
WP205	IL-7 signaling pathway	7/1472	25/5963	0.424312498170574	0.995573047655631	0.815948390193584	2534/3559/3575/3718/6772/6774/6776	7
WP4950	16p11.2 distal deletion syndrome	7/1472	25/5963	0.424312498170574	0.995573047655631	0.815948390193584	718/3732/8519/3717/3791/5350/7185	7
WP581	EPO receptor signaling	7/1472	25/5963	0.424312498170574	0.995573047655631	0.815948390193584	3717/5163/5788/8651/6772/6774/6776	7
WP408	Oxidative stress response	8/1472	29/5963	0.427520835277539	0.99624689859452	0.816500662666318	1536/3726/4128/4501/1728/6648/54578/7498	8
WP4756	Renin-angiotensin-aldosterone system (RAAS)	9/1472	33/5963	0.429997699329108	0.99624689859452	0.816500662666318	1636/183/185/57118/816/64764/84699/9586/3283	9
WP4148	Splicing factor NOVA regulated synaptic proteins	10/1472	37/5963	0.431952068578805	0.99624689859452	0.816500662666318	288/23705/1600/1946/2036/2037/2898/3763/22854/2054	10
WP4331	Neovascularisation processes	10/1472	37/5963	0.431952068578805	0.99624689859452	0.816500662666318	2324/3091/3791/4318/4791/4854/4855/5155/7042/7043	10
WP3611	Photodynamic therapy-induced AP-1 survival signaling	13/1472	49/5963	0.43583119222124	0.998669493943074	0.818486165166008	602/890/898/1029/2252/1839/3458/3569/3726/5600/6300/4313/7124	13
WP585	Interferon type I signaling pathways	14/1472	53/5963	0.43668758314485	0.998669493943074	0.818486165166008	2534/3455/10379/27250/5293/5788/8651/9021/6772/6774/6775/6776/7409/7535	14
WP185	Integrin-mediated cell adhesion	24/1472	94/5963	0.463782693303585	0.999999999999965	0.819576616818771	10000/11131/827/857/2534/3672/22801/3673/3678/3655/3679/8516/3683/3684/3685/3687/3689/3690/3694/6300/5880/7145/10451/7791	24
WP3656	Interleukin-1 induced activation of NF-kB	3/1472	10/5963	0.465000336742697	0.999999999999965	0.819576616818771	84962/3552/92610	3
WP4846	SARS-CoV-2 and COVID-19 pathway	3/1472	10/5963	0.465000336742697	0.999999999999965	0.819576616818771	59272/1514/340024	3
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	3/1472	10/5963	0.465000336742697	0.999999999999965	0.819576616818771	718/629/1675	3
WP4584	Biomarkers for pyrimidine metabolism disorders	4/1472	14/5963	0.467622017939575	0.999999999999965	0.819576616818771	1152/51251/6241/1890	4
WP5061	Fatty acid transporters	4/1472	14/5963	0.467622017939575	0.999999999999965	0.819576616818771	2180/2182/2168/2172	4
WP560	TGF-beta receptor signaling	13/1472	50/5963	0.468421899353803	0.999999999999965	0.819576616818771	25805/2022/3458/3624/3694/51176/864/5054/6498/6696/6772/6774/7124	13
WP3670	Interactions between LOXL4 and oxidative stress pathway	5/1472	18/5963	0.468871137257131	0.999999999999965	0.819576616818771	308/1280/2252/3490/1728	5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	5/1472	18/5963	0.468871137257131	0.999999999999965	0.819576616818771	1014/1004/6615/3371/7431	5
WP3927	BMP signaling in eyelid development	5/1472	18/5963	0.468871137257131	0.999999999999965	0.819576616818771	2255/2296/3625/5308/6469	5
WP4533	Transcription co-factors SKI and SKIL protein partners	5/1472	18/5963	0.468871137257131	0.999999999999965	0.819576616818771	26524/23314/6498/6788/7004	5
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	6/1472	22/5963	0.469466156482599	0.999999999999965	0.819576616818771	1244/9429/2052/5600/6300/1728	6
WP4537	Hippo-Yap signaling pathway	6/1472	22/5963	0.469466156482599	0.999999999999965	0.819576616818771	3627/26524/11184/9448/6788/7004	6
WP4875	Disruption of postsynaptic signaling by CNV	7/1472	26/5963	0.469701054113958	0.999999999999965	0.819576616818771	816/1740/2906/9456/22871/57555/9378	7
WP4963	p53 transcriptional gene network	15/1472	59/5963	0.497677021502103	0.999999999999965	0.819576616818771	8659/6347/126129/6376/55332/3383/10379/9636/4688/5366/5371/5268/5054/6513/23657	15
WP4673	Male infertility	25/1472	100/5963	0.509650402302215	0.999999999999965	0.819576616818771	5243/27161/338/675/1191/56603/94240/2346/3122/4057/4313/4318/4843/4846/1728/55124/29968/9985/113235/6648/6948/7124/9319/10537/7516	25
WP34	Ovarian infertility	6/1472	23/5963	0.517656026071004	0.999999999999965	0.819576616818771	1051/2701/5618/23224/7783/7784	6
WP1584	Type II diabetes mellitus	5/1472	19/5963	0.521951850690902	0.999999999999965	0.819576616818771	773/3651/23533/6514/7124	5
WP2895	Differentiation of white and brown adipocyte	5/1472	19/5963	0.521951850690902	0.999999999999965	0.819576616818771	1051/253738/27129/51316/10891	5
WP325	Triacylglyceride synthesis	5/1472	19/5963	0.521951850690902	0.999999999999965	0.819576616818771	56895/2819/3990/4023/80168	5
WP5194	Synthesis of ceramides and 1-deoxyceramides	5/1472	19/5963	0.521951850690902	0.999999999999965	0.819576616818771	53947/2683/1674/259230/8877	5
WP1946	Cori cycle	4/1472	15/5963	0.527476013826944	0.999999999999965	0.819576616818771	3939/5214/6513/6514	4
WP3	Transcriptional activation by NRF2 in response to phytochemicals	4/1472	15/5963	0.527476013826944	0.999999999999965	0.819576616818771	1051/2939/1728/23657	4
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	4/1472	15/5963	0.527476013826944	0.999999999999965	0.819576616818771	699/701/991/1062	4
WP5101	Congenital generalized lipodystrophy (CGL)	4/1472	15/5963	0.527476013826944	0.999999999999965	0.819576616818771	857/2534/3091/23175	4
WP3630	NAD metabolism, sirtuins and aging	3/1472	11/5963	0.535142758483125	0.999999999999965	0.819576616818771	3091/10135/6098	3
WP4271	Vitamin B12 disorders	3/1472	11/5963	0.535142758483125	0.999999999999965	0.819576616818771	8029/6947/6948	3
WP3940	One-carbon metabolism and related pathways	10/1472	40/5963	0.542502629830649	0.999999999999965	0.819576616818771	64902/586/587/23743/55349/56994/29958/1759/2882/6648	10
WP4222	Phosphodiesterases in neuronal function	10/1472	40/5963	0.542502629830649	0.999999999999965	0.819576616818771	196883/1139/2906/2977/10846/5153/5137/5142/5145/84152	10
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	9/1472	36/5963	0.546688614465247	0.999999999999965	0.819576616818771	684/3429/8519/10581/10410/3726/5600/6300/6196	9
WP3298	Melatonin metabolism and effects	8/1472	32/5963	0.551513239259242	0.999999999999965	0.819576616818771	1545/1557/1565/1906/4128/406938/4543/6817	8
WP4542	Leukocyte-intrinsic Hippo pathway functions	8/1472	32/5963	0.551513239259242	0.999999999999965	0.819576616818771	50943/3683/26524/4023/639/83593/6788/7004	8
WP4481	Resistin as a regulator of inflammation	7/1472	28/5963	0.557186951247552	0.999999999999965	0.819576616818771	10000/3569/5293/23236/5333/5336/7124	7
WP4655	Cytosolic DNA-sensing pathway	14/1472	57/5963	0.559921975552705	0.999999999999965	0.819576616818771	9447/834/843/841/6351/9560/3627/3606/3553/90865/3569/9636/10622/81030	14
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	12/1472	49/5963	0.567845878510264	0.999999999999965	0.819576616818771	27161/1051/1513/8091/3726/51176/4128/4129/6696/7042/4982/7480	12
WP2355	Corticotropin-releasing hormone signaling pathway	19/1472	78/5963	0.570705901680947	0.999999999999965	0.819576616818771	1393/8061/2697/2784/10681/3283/3606/3726/3861/4846/3164/4929/5336/5579/10411/6822/6925/7020/7099	19
WP3580	Methionine de novo and salvage pathway	5/1472	20/5963	0.572593446998853	0.999999999999965	0.819576616818771	51074/55349/259307/4953/6723	5
WP3640	Imatinib and chronic myeloid leukemia	5/1472	20/5963	0.572593446998853	0.999999999999965	0.819576616818771	5243/9429/2321/5159/11040	5
WP3645	NAD+ biosynthetic pathways	5/1472	20/5963	0.572593446998853	0.999999999999965	0.819576616818771	952/3620/10135/23475/6999	5
WP4224	Purine metabolism and related disorders	5/1472	20/5963	0.572593446998853	0.999999999999965	0.819576616818771	100/316/3614/4860/7498	5
WP2332	Interleukin-11 signaling pathway	10/1472	41/5963	0.577658587308127	0.999999999999965	0.819576616818771	332/2534/3383/3589/3572/3673/3717/9021/6772/6774	10
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	4/1472	16/5963	0.583828128314045	0.999999999999965	0.819576616818771	3157/3949/10891/6319	4
WP22	IL-9 signaling pathway	4/1472	16/5963	0.583828128314045	0.999999999999965	0.819576616818771	3718/6772/6774/6776	4
WP3644	NAD+ metabolism	4/1472	16/5963	0.583828128314045	0.999999999999965	0.819576616818771	952/10135/23057/349565	4
WP368	Mitochondrial long chain fatty acid beta-oxidation	4/1472	16/5963	0.583828128314045	0.999999999999965	0.819576616818771	35/80221/2180/2182	4
WP4225	Pyrimidine metabolism and related diseases	4/1472	16/5963	0.583828128314045	0.999999999999965	0.819576616818771	51251/5009/6241/1890	4
WP4217	Ebola virus infection in host	30/1472	124/5963	0.585994358532044	0.999999999999965	0.819576616818771	432/684/857/11314/93978/1514/2316/2318/3108/3112/3119/3122/3123/3134/3384/3672/3673/3678/3655/3685/3690/4240/4791/5293/8503/9021/6772/7020/91937/7099	30
WP1601	Fluoropyrimidine activity	7/1472	29/5963	0.598444351783466	0.999999999999965	0.819576616818771	9429/8824/6241/7083/1890/7371/7378	7
WP4211	Transcriptional cascade regulating adipogenesis	3/1472	12/5963	0.599713644894522	0.999999999999965	0.819576616818771	1051/1959/10365	3
WP536	Calcium regulation in cardiac cells	30/1472	125/5963	0.605869815162117	0.999999999999965	0.819576616818771	196883/147/773/775/777/811/816/1131/2697/2701/2702/127534/2709/10052/2784/59345/10681/51764/2786/2869/3760/5350/5577/5579/5996/6004/64407/10287/5999/8490	30
WP1528	Physiological and pathological hypertrophy of the heart	6/1472	25/5963	0.608157822312333	0.999999999999965	0.819576616818771	183/1906/3572/5600/5579/6774	6
WP4630	Measles virus infection	28/1472	117/5963	0.61138795073391	0.999999999999965	0.819576616818771	841/898/940/915/3310/3455/3552/3553/3559/3560/3569/10379/3718/4478/4791/4939/4940/5293/8503/6504/6772/6774/6776/7097/7099/54106/7128/7161	28
WP304	Kit receptor signaling pathway	14/1472	59/5963	0.617783345849075	0.999999999999965	0.819576616818771	695/2534/3635/3717/3726/4067/5579/10603/6615/8651/6772/6774/6776/7409	14
WP5072	Modulators of TCR signaling and T cell activation	14/1472	59/5963	0.617783345849075	0.999999999999965	0.819576616818771	84433/940/915/921/3702/3937/1326/11184/399/4068/8651/7128/7409/7535	14
WP4758	Nephrotic syndrome	9/1472	38/5963	0.619005077077174	0.999999999999965	0.819576616818771	54443/8542/1286/1493/8029/2262/3913/4868/5420	9
WP262	Ebstein-Barr virus LMP1 signaling	5/1472	21/5963	0.620269659575495	0.999999999999965	0.819576616818771	6364/4791/9260/7124/7185	5
WP170	Nuclear receptors	8/1472	34/5963	0.627567686145222	0.999999999999965	0.819576616818771	9970/7025/3164/4929/5915/6097/6258/7068	8
WP3286	Copper homeostasis	12/1472	51/5963	0.629556628406048	0.999999999999965	0.819576616818771	8754/4489/4493/4494/4495/4496/4500/4501/4502/4504/79689/54739	12
WP3874	Canonical and non-canonical TGF-B signaling	4/1472	17/5963	0.636064135254889	0.999999999999965	0.819576616818771	26585/4015/4016/4017	4
WP4784	Proteoglycan biosynthesis	4/1472	17/5963	0.636064135254889	0.999999999999965	0.819576616818771	9469/22856/55790/1836	4
WP4912	SARS coronavirus and innate immunity	4/1472	17/5963	0.636064135254889	0.999999999999965	0.819576616818771	59272/3455/10379/6772	4
WP4149	White fat cell differentiation	7/1472	30/5963	0.637621681884541	0.999999999999965	0.819576616818771	1051/1879/1959/3662/10365/6776/7480	7
WP4787	Osteoblast differentiation and related diseases	23/1472	98/5963	0.64911849363055	0.999999999999965	0.819576616818771	2246/2255/2247/2252/2254/2261/11211/23493/3549/5600/6300/4854/4855/5288/5293/8503/23533/5579/6772/7480/7481/7472/7474	23
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	3/1472	13/5963	0.65807157725464	0.999999999999965	0.819576616818771	8309/4312/5743	3
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	3/1472	13/5963	0.65807157725464	0.999999999999965	0.819576616818771	3685/3690/7134	3
WP3958	GPR40 pathway	3/1472	13/5963	0.65807157725464	0.999999999999965	0.819576616818771	23236/5333/5336	3
WP692	Sulfation biotransformation reaction	3/1472	13/5963	0.65807157725464	0.999999999999965	0.819576616818771	6817/6799/6822	3
WP2371	Parkinson's disease pathway	8/1472	35/5963	0.662816262598605	0.999999999999965	0.819576616818771	898/1644/120892/5600/6300/9627/23208/9246	8
WP357	Fatty acid biosynthesis	5/1472	22/5963	0.664623631073405	0.999999999999965	0.819576616818771	2180/2182/1891/55268/6319	5
WP1742	TP53 network	4/1472	18/5963	0.683833563254249	0.999999999999965	0.819576616818771	1029/5366/8626/7161	4
WP2525	Trans-sulfuration and one-carbon metabolism	6/1472	27/5963	0.688423035538485	0.999999999999965	0.819576616818771	275/875/25902/10797/26227/29968	6
WP2643	Nanoparticle-mediated activation of receptor signaling	6/1472	27/5963	0.688423035538485	0.999999999999965	0.819576616818771	10000/1277/3672/5600/6300/5293	6
WP3869	Cannabinoid receptor signaling	6/1472	27/5963	0.688423035538485	0.999999999999965	0.819576616818771	1557/1559/1576/5600/6300/5577	6
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	6/1472	27/5963	0.688423035538485	0.999999999999965	0.819576616818771	1959/3315/26353/4359/5865/79628	6
WP5121	Sphingolipid metabolism in senescence	6/1472	27/5963	0.688423035538485	0.999999999999965	0.819576616818771	23236/5579/1901/9294/8877/7015	6
WP2272	Pathogenic Escherichia coli infection	11/1472	49/5963	0.6949383701846	0.999999999999965	0.819576616818771	10095/9076/2534/3059/23643/7099/79861/7280/10381/84617/7454	11
WP4357	NRF2-ARE regulation	5/1472	23/5963	0.705447965796294	0.999999999999965	0.819576616818771	1051/2534/2939/1728/23657	5
WP4483	Relationship between inflammation, COX-2 and EGFR	5/1472	23/5963	0.705447965796294	0.999999999999965	0.819576616818771	10000/4312/5293/51365/5743	5
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	5/1472	23/5963	0.705447965796294	0.999999999999965	0.819576616818771	3553/3569/10135/23057/6513	5
WP4255	Non-small cell lung cancer	16/1472	71/5963	0.707056448258933	0.999999999999965	0.819576616818771	10000/841/1029/1381/1382/3718/5163/5293/8503/5336/5579/5915/83593/6258/6774/6776	16
WP5205	CLOCKED CONTROLLED AUTOPHAGY IN BONE METABOLISM	16/1472	71/5963	0.707056448258933	0.999999999999965	0.819576616818771	393/8553/651/653/8646/115908/1513/22943/3569/3717/4772/10507/5176/4982/7480/7474	16
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	3/1472	14/5963	0.710012366158748	0.999999999999965	0.819576616818771	1466/283120/5366	3
WP4540	Hippo signaling regulation pathways	19/1472	84/5963	0.710578598623227	0.999999999999965	0.819576616818771	1009/1014/1001/1003/1004/1969/2261/2321/2324/3791/26524/51176/5159/23236/5577/5579/6788/7004/7010	19
WP49	IL-2 signaling pathway	9/1472	41/5963	0.714975282120405	0.999999999999965	0.819576616818771	2534/3559/3560/3718/9111/9021/6772/6774/6776	9
WP2870	Extracellular vesicle-mediated signaling in recipient cells	6/1472	28/5963	0.724214694890558	0.999999999999965	0.819576616818771	3082/4240/23533/7042/7043/7474	6
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	4/1472	19/5963	0.727002019937808	0.999999999999965	0.819576616818771	3091/3939/5163/6513	4
WP4961	STING pathway in Kawasaki-like disease and COVID-19	4/1472	19/5963	0.727002019937808	0.999999999999965	0.819576616818771	2152/2212/3553/114548	4
WP5181	Roles of ceramides in the development of insulin resistance	4/1472	19/5963	0.727002019937808	0.999999999999965	0.819576616818771	2180/3651/7124/7185	4
WP244	Alpha 6 beta 4 signaling pathway	7/1472	33/5963	0.740852124297937	0.999999999999965	0.819576616818771	3655/284217/3909/3911/3913/3915/3918	7
WP4925	Unfolded protein response	5/1472	24/5963	0.742661918764184	0.999999999999965	0.819576616818771	841/3309/3553/5366/7494	5
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	9/1472	42/5963	0.743173455748845	0.999999999999965	0.819576616818771	330/841/6347/3569/4318/4791/7124/51330/7185	9
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	9/1472	42/5963	0.743173455748845	0.999999999999965	0.819576616818771	72/3689/3690/3694/11184/9448/259230/6788/7004	9
WP1992	Genes targeted by miRNAs in adipocytes	2/1472	10/5963	0.749053286824852	0.999999999999965	0.819576616818771	2078/2697	2
WP2007	Iron metabolism in placenta	2/1472	10/5963	0.749053286824852	0.999999999999965	0.819576616818771	30061/7036	2
WP2333	Trans-sulfuration pathway	2/1472	10/5963	0.749053286824852	0.999999999999965	0.819576616818771	875/4357	2
WP4259	Disorders of folate metabolism and transport	2/1472	10/5963	0.749053286824852	0.999999999999965	0.819576616818771	10840/113235	2
WP5050	TCA cycle in senescence	2/1472	10/5963	0.749053286824852	0.999999999999965	0.819576616818771	4199/5163	2
WP5182	Pro-survival signaling of neuroprotectin D1	3/1472	15/5963	0.755646454241699	0.999999999999965	0.819576616818771	330/841/7124	3
WP3972	PDGFR-beta pathway	6/1472	29/5963	0.757024349614147	0.999999999999965	0.819576616818771	3717/5159/5579/6772/6774/6776	6
WP5117	Cohesin complex - Cornelia de Lange syndrome	6/1472	29/5963	0.757024349614147	0.999999999999965	0.819576616818771	9212/113130/983/157570/5347/9985	6
WP382	MAPK signaling pathway	48/1472	210/5963	0.758206299574724	0.999999999999965	0.819576616818771	10000/773/775/777/9254/785/994/11221/1844/1846/1849/2246/2255/2259/2247/2252/2254/2261/2316/2318/3310/3315/3552/3553/3554/120892/9064/1326/11184/9448/5600/6300/22808/4772/4791/3164/5155/5159/283748/5778/5880/10125/25780/115727/6788/7042/7043/7124	48
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	17/1472	78/5963	0.763469295257432	0.999999999999965	0.819576616818771	467/80319/22943/8061/11211/283120/51176/5328/5176/6423/6425/64321/7020/7480/7481/7472/7474	17
WP2878	PPAR-alpha pathway	4/1472	20/5963	0.765604163172547	0.999999999999965	0.819576616818771	335/345/983/2168	4
WP1971	Integrated cancer pathway	9/1472	43/5963	0.769399715410341	0.999999999999965	0.819576616818771	641/672/841/994/983/1030/4312/5347/6772	9
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	9/1472	43/5963	0.769399715410341	0.999999999999965	0.819576616818771	10000/775/816/2906/116443/9456/5293/8503/85358	9
WP127	IL-5 signaling pathway	8/1472	39/5963	0.782392782944073	0.999999999999965	0.819576616818771	695/1439/3568/3717/4067/6772/6774/6776	8
WP4223	Ras signaling	36/1472	161/5963	0.782479152507933	0.999999999999965	0.819576616818771	10000/1969/2113/2261/2321/2324/2784/59345/10681/51764/2786/3363/3791/8844/283455/22808/5159/5293/8503/51365/84647/5320/50487/283748/5336/5579/5880/8437/64926/10125/25780/115727/83593/25759/7010/7535	36
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	14/1472	66/5963	0.786060006932056	0.999999999999965	0.819576616818771	2222/2224/3157/3422/3638/3949/23175/4023/4047/4597/6319/10802/9871/6713	14
WP3858	Toll-like receptor signaling related to MyD88	6/1472	30/5963	0.786875016546549	0.999999999999965	0.819576616818771	4791/7096/7097/7099/51311/54106	6
WP254	Apoptosis	18/1472	84/5963	0.793263490782462	0.999999999999965	0.819576616818771	330/332/834/843/841/1029/3002/8739/3659/3662/4049/5366/5551/7124/7133/8626/7161/7185	18
WP4815	Glycosaminoglycan degradation	3/1472	16/5963	0.795296837148081	0.999999999999965	0.819576616818771	10855/3373/8692	3
WP4970	Galanin receptor pathway	3/1472	16/5963	0.795296837148081	0.999999999999965	0.819576616818771	3569/10891/7020	3
WP3679	Cell-type dependent selectivity of CCK2R signaling	2/1472	11/5963	0.79658895978968	0.999999999999965	0.819576616818771	952/23236	2
WP4589	Major receptors targeted by epinephrine and norepinephrine	2/1472	11/5963	0.79658895978968	0.999999999999965	0.819576616818771	196883/150	2
WP4788	Autosomal recessive osteopetrosis pathways	2/1472	11/5963	0.79658895978968	0.999999999999965	0.819576616818771	29887/10312	2
WP4919	Neuroinflammation	2/1472	11/5963	0.79658895978968	0.999999999999965	0.819576616818771	4843/7099	2
WP4947	Nitric oxide metabolism in cystic fibrosis	2/1472	11/5963	0.79658895978968	0.999999999999965	0.819576616818771	4843/4846	2
WP3527	Pre-implantation embryo	7/1472	35/5963	0.797073639124113	0.999999999999965	0.819576616818771	366/55509/11189/94234/3662/5460/7004	7
WP4288	MTHFR deficiency	4/1472	21/5963	0.799800516960088	0.999999999999965	0.819576616818771	55349/56994/2906/259230	4
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	4/1472	21/5963	0.799800516960088	0.999999999999965	0.819576616818771	841/5600/6300/7124	4
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	5/1472	26/5963	0.806429154806982	0.999999999999965	0.819576616818771	857/1051/3717/5618/23508	5
WP3851	TLR4 signaling and tolerance	5/1472	26/5963	0.806429154806982	0.999999999999965	0.819576616818771	3569/3635/11213/7099/7124	5
WP3941	Oxidative damage response	8/1472	40/5963	0.806782830426274	0.999999999999965	0.819576616818771	715/716/717/721/728/7124/7133/7185	8
WP4844	Influence of laminopathies on Wnt signaling	6/1472	31/5963	0.813844764570221	0.999999999999965	0.819576616818771	27161/1051/8091/51176/6696/7480	6
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	6/1472	31/5963	0.813844764570221	0.999999999999965	0.819576616818771	3283/4318/5163/5293/23236/5579	6
WP2018	RANKL/RANK signaling pathway	11/1472	54/5963	0.813869336569773	0.999999999999965	0.819576616818771	1513/2274/3383/4067/4772/4791/6688/6772/4982/7185/7412	11
WP710	DNA damage response (only ATM dependent)	22/1472	103/5963	0.816405917013405	0.999999999999965	0.819576616818771	10000/604/1029/8061/3949/51176/197259/4791/5163/5288/5293/8503/23533/5328/5366/5880/6648/7161/7480/7481/7472/7474	22
WP4290	Metabolic reprogramming in colon cancer	8/1472	41/5963	0.829039205773152	0.999999999999965	0.819576616818771	229/2023/3101/3939/5315/29968/5831/6513	8
WP4830	GDNF/RET signaling axis	3/1472	17/5963	0.829418130410908	0.999999999999965	0.819576616818771	2296/26585/64321	3
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	4/1472	22/5963	0.829839824934906	0.999999999999965	0.819576616818771	597/10017/3655/5744	4
WP4806	EGFR tyrosine kinase inhibitor resistance	17/1472	82/5963	0.832482952335677	0.999999999999965	0.819576616818771	10000/2247/2261/3082/3569/3717/3791/22808/3084/5155/5159/5293/8503/5336/5579/25759/6774	17
WP2533	Glycerophospholipid biosynthetic pathway	5/1472	27/5963	0.833248727368003	0.999999999999965	0.819576616818771	56994/2819/23175/5293/5320	5
WP3931	Embryonic stem cell pluripotency pathways	19/1472	91/5963	0.834071388595289	0.999999999999965	0.819576616818771	90/10000/2246/2255/2259/2247/2252/2254/2261/3572/6300/5155/5159/5293/6774/7480/7481/7472/7474	19
WP2513	Nanoparticle triggered regulated necrosis	2/1472	12/5963	0.835964022768712	0.999999999999965	0.819576616818771	841/7124	2
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	2/1472	12/5963	0.835964022768712	0.999999999999965	0.819576616818771	22943/6750	2
WP4504	Cysteine and methionine catabolism	2/1472	12/5963	0.835964022768712	0.999999999999965	0.819576616818771	875/4357	2
WP5173	Disorders of galactose metabolism 	2/1472	12/5963	0.835964022768712	0.999999999999965	0.819576616818771	8908/6514	2
WP2857	Mesodermal commitment pathway	26/1472	122/5963	0.836210817428505	0.999999999999965	0.819576616818771	90/92/8728/10973/57198/8553/55704/8646/1466/22943/2296/2627/8091/3624/3717/51176/83881/5080/5308/5460/5915/6615/64321/6925/55809/10451	26
WP23	B cell receptor signaling pathway	20/1472	96/5963	0.841923149361958	0.999999999999965	0.819576616818771	604/695/84433/973/27071/2113/2534/3059/3635/3662/7462/4067/11184/118788/5336/5579/5788/5880/25780/7409	20
WP3303	RAC1/PAK1/p38/MMP2 pathway	13/1472	65/5963	0.847954020505319	0.999999999999965	0.819576616818771	285/9068/332/9046/5600/6300/4313/4843/6774/6776/7010/7075/79931	13
WP3658	Wnt/beta-catenin signaling pathway in leukemia	4/1472	23/5963	0.856027584753562	0.999999999999965	0.819576616818771	22943/51176/5371/7704	4
WP3845	Canonical and non-canonical Notch signaling	4/1472	23/5963	0.856027584753562	0.999999999999965	0.819576616818771	51176/4237/4854/4855	4
WP3982	miRNA regulation of p53 pathway in prostate cancer	4/1472	23/5963	0.856027584753562	0.999999999999965	0.819576616818771	841/192668/5366/5054	4
WP5038	Mitochondrial immune response to SARS-CoV-2	5/1472	28/5963	0.856951777906578	0.999999999999965	0.819576616818771	1636/59272/185/1514/4791	5
WP4942	15q13.3 copy number variation syndrome	2/1472	13/5963	0.86830810377127	0.999999999999965	0.819576616818771	1139/2534	2
WP3888	VEGFA-VEGFR2 signaling pathway	92/1472	409/5963	0.870146267591014	0.999999999999965	0.819576616818771	23597/8754/9510/56999/301/81575/22899/10973/332/811/813/857/6347/1003/79094/1397/1466/1536/1558/22943/4189/1847/1960/2022/1969/2078/2113/2152/2274/24147/2321/6624/2534/2697/1839/51564/3142/3315/5654/10525/3383/3486/3490/3685/3690/3791/9079/3939/3984/6300/4319/4323/4313/79812/653361/4688/91624/4772/4846/4855/3164/4929/8013/441478/8828/5034/55872/5228/5328/5329/4860/9588/5579/5743/57381/27289/1901/57758/6386/23753/6401/9047/25759/357/6541/6648/6748/6772/6774/7004/8794/81567	92
WP4666	Hepatitis B infection	28/1472	134/5963	0.871992757499834	0.999999999999965	0.819576616818771	10000/332/843/841/64764/84699/9586/1959/1960/3569/3717/3718/5600/6300/4318/4772/5293/8503/5579/6772/6774/6775/6776/7042/7043/7097/7099/7124	28
WP4698	Vitamin D-sensitive calcium signaling in depression	5/1472	29/5963	0.877769992134168	0.999999999999965	0.819576616818771	775/1593/1594/2906/7166	5
WP2828	Bladder cancer	7/1472	39/5963	0.881018476653669	0.999999999999965	0.819576616818771	1029/2261/1839/4312/4313/4318/1890	7
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	14/1472	72/5963	0.882171183277054	0.999999999999965	0.819576616818771	80319/22943/8061/11211/51176/5328/5176/6423/6425/64321/7480/7481/7472/7474	14
WP4722	Glycerolipids and glycerophospholipids	3/1472	19/5963	0.88319748582432	0.999999999999965	0.819576616818771	56895/56994/80339	3
WP5103	Progeria-associated lipodystrophy	3/1472	19/5963	0.88319748582432	0.999999999999965	0.819576616818771	2200/3763/5965	3
WP51	Regulation of actin cytoskeleton	26/1472	127/5963	0.890003727293396	0.999999999999965	0.819576616818771	50649/9459/1131/81624/2149/2246/2255/2259/2247/2252/2254/2261/3672/3984/22808/4478/5155/5159/5288/5293/8503/23533/5880/7409/7429/7454	26
WP47	Hedgehog signaling pathway	2/1472	14/5963	0.89469072670669	0.999999999999965	0.819576616818771	3549/6469	2
WP53	ID signaling pathway	2/1472	14/5963	0.89469072670669	0.999999999999965	0.819576616818771	898/2004	2
WP143	Fatty acid beta-oxidation	5/1472	30/5963	0.895948987251692	0.999999999999965	0.819576616818771	35/2180/2182/3990/4023	5
WP2363	Gastric cancer network 2	5/1472	30/5963	0.895948987251692	0.999999999999965	0.819576616818771	1297/79075/51316/255488/11065	5
WP314	Fas ligand pathway and stress induction of heat shock proteins	7/1472	41/5963	0.910709066707735	0.999999999999965	0.819576616818771	397/843/841/3315/3552/8767/7124	7
WP3915	Angiopoietin-like protein 8 regulatory pathway	25/1472	125/5963	0.911177099565286	0.999999999999965	0.819576616818771	64240/64241/1576/1734/2203/4023/9064/1326/11184/9448/5600/6300/51085/5105/5288/5293/8503/23433/6196/27330/6319/25759/6567/6513/7068	25
WP1772	Apoptosis modulation and signaling	16/1472	84/5963	0.912138865481961	0.999999999999965	0.819576616818771	597/10017/330/332/664/834/843/841/1029/8739/3554/8682/5366/5783/8794/7133	16
WP428	Wnt signaling	19/1472	98/5963	0.913572896861961	0.999999999999965	0.819576616818771	816/80319/22943/8061/11211/51176/4772/5328/23236/5579/5176/6423/6425/64321/57216/7480/7481/7472/7474	19
WP1422	Sphingolipid pathway	4/1472	26/5963	0.914894960184902	0.999999999999965	0.819576616818771	56624/9514/259230/8877	4
WP2037	Prolactin signaling pathway	14/1472	75/5963	0.915230245239223	0.999999999999965	0.819576616818771	2316/2534/3659/3717/4843/5618/6196/8651/9021/6772/6774/6776/7409/7535	14
WP4872	MAP3K1 role in promoting and blocking gonadal determination	2/1472	15/5963	0.916082153239766	0.999999999999965	0.819576616818771	2254/5600	2
WP4962	Airway smooth muscle cell contraction	2/1472	15/5963	0.916082153239766	0.999999999999965	0.819576616818771	952/23236	2
WP4905	1q21.1 copy number variation syndrome	3/1472	21/5963	0.921307370592744	0.999999999999965	0.819576616818771	2330/2697/2702	3
WP2516	ATM signaling pathway	6/1472	37/5963	0.923564655941621	0.999999999999965	0.819576616818771	8120/672/891/898/983/7161	6
WP2359	Parkin-ubiquitin proteasomal system pathway	11/1472	62/5963	0.927033442556501	0.999999999999965	0.819576616818771	834/841/898/3309/3310/9627/79861/7280/10381/84617/9246	11
WP3594	Circadian rhythm genes	32/1472	159/5963	0.928320386598095	0.999999999999965	0.819576616818771	100/134/56938/8553/1141/1390/1644/1960/2155/51738/50865/6928/9456/3363/3569/4543/4547/10135/22871/4843/5371/10891/5551/5593/60675/5730/6097/5054/150094/6532/7166/463	32
WP2112	IL-17 signaling pathway	4/1472	27/5963	0.929094305022623	0.999999999999965	0.819576616818771	1051/3605/3717/6774	4
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	2/1472	16/5963	0.933337198395721	0.999999999999965	0.819576616818771	51176/6925	2
WP500	Glycogen synthesis and degradation	6/1472	38/5963	0.934861198481031	0.999999999999965	0.819576616818771	8908/3099/3101/80201/5522/5523	6
WP4482	Vitamin D in inflammatory diseases	3/1472	22/5963	0.935749614643982	0.999999999999965	0.819576616818771	3569/4772/7124	3
WP399	Wnt signaling pathway and pluripotency	16/1472	87/5963	0.936721719377929	0.999999999999965	0.819576616818771	960/8061/11211/3949/51176/120892/4316/5328/5460/5522/5523/5579/7480/7481/7472/7474	16
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	5/1472	33/5963	0.937120787331693	0.999999999999965	0.819576616818771	3455/10379/4939/4940/6772	5
WP4150	Wnt signaling in kidney disease	4/1472	28/5963	0.941118059541964	0.999999999999965	0.819576616818771	7480/7481/7472/7474	4
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	1/1472	10/5963	0.941425728129829	0.999999999999965	0.819576616818771	672	1
WP5120	Inclusion body myositis	1/1472	10/5963	0.941425728129829	0.999999999999965	0.819576616818771	4791	1
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	1/1472	10/5963	0.941425728129829	0.999999999999965	0.819576616818771	51311	1
WP2038	Microtubule cytoskeleton regulation	7/1472	44/5963	0.943235459598375	0.999999999999965	0.819576616818771	9212/983/2151/11004/3984/6774/10420	7
WP410	Exercise-induced circadian regulation	7/1472	44/5963	0.943235459598375	0.999999999999965	0.819576616818771	1051/50486/2947/3108/3422/11030/10381	7
WP100	Glutathione metabolism	2/1472	17/5963	0.947193074127029	0.999999999999965	0.819576616818771	290/2938	2
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	2/1472	17/5963	0.947193074127029	0.999999999999965	0.819576616818771	3685/3690	2
WP3871	Valproic acid pathway	1/1472	11/5963	0.955909404963844	0.999999999999965	0.819576616818771	1559	1
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	1/1472	11/5963	0.955909404963844	0.999999999999965	0.819576616818771	604	1
WP4313	Ferroptosis	10/1472	61/5963	0.956775355952718	0.999999999999965	0.819576616818771	2180/2182/246/875/1536/1803/2222/3315/30061/23657	10
WP3584	MECP2 and associated Rett syndrome	9/1472	56/5963	0.956945577998835	0.999999999999965	0.819576616818771	604/2247/2289/2530/2892/2893/54715/6750/6890	9
WP4016	DNA IR-damage and cellular response via ATR	13/1472	76/5963	0.957837037117151	0.999999999999965	0.819576616818771	604/672/675/8318/983/63967/9156/2175/2305/5347/5371/353497/5965	13
WP466	DNA replication	6/1472	41/5963	0.960368353226894	0.999999999999965	0.819576616818771	8318/990/8317/55388/4998/23594	6
WP179	Cell cycle	21/1472	115/5963	0.961172561271357	0.999999999999965	0.819576616818771	699/890/891/898/8556/991/994/8318/990/8317/983/1029/1030/10459/4998/23594/9088/5347/7042/7043/7272	21
WP4906	3q29 copy number variation syndrome	8/1472	52/5963	0.963575685562595	0.999999999999965	0.819576616818771	84984/3091/375387/80235/8503/30061/123264/6776	8
WP186	Homologous recombination	1/1472	12/5963	0.966813530617947	0.999999999999965	0.819576616818771	675	1
WP2023	Cell differentiation - expanded index	1/1472	12/5963	0.966813530617947	0.999999999999965	0.819576616818771	6774	1
WP2290	RalA downstream regulated genes	1/1472	12/5963	0.966813530617947	0.999999999999965	0.819576616818771	5880	1
WP3933	Kennedy pathway from sphingolipids	1/1472	12/5963	0.966813530617947	0.999999999999965	0.819576616818771	56994	1
WP2636	Common pathways underlying drug addiction	4/1472	31/5963	0.966876829426341	0.999999999999965	0.819576616818771	72/2892/2893/5579	4
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	2/1472	19/5963	0.967108015217135	0.999999999999965	0.819576616818771	2683/8877	2
WP1403	AMP-activated protein kinase (AMPK) signaling	9/1472	58/5963	0.968014536425309	0.999999999999965	0.819576616818771	147/890/891/126129/5209/5293/8503/23236/55437	9
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	8/1472	53/5963	0.968845552129309	0.999999999999965	0.819576616818771	843/841/3627/3458/9636/5600/6300/7124	8
WP4249	Hedgehog signaling pathway	5/1472	37/5963	0.969197451503001	0.999999999999965	0.819576616818771	91653/2619/64399/3549/6469	5
WP524	G13 signaling pathway	5/1472	37/5963	0.969197451503001	0.999999999999965	0.819576616818771	397/398/3984/5293/7454	5
WP4321	Thermogenesis	17/1472	98/5963	0.96936301750414	0.999999999999965	0.819576616818771	2180/2182/196883/656/126129/64764/84699/9586/2641/152831/5600/6300/4881/10891/5593/6196/27330	17
WP2586	Aryl hydrocarbon receptor pathway	6/1472	43/5963	0.971914982942612	0.999999999999965	0.819576616818771	1545/4023/135112/1728/5743/7124	6
WP2853	Endoderm differentiation	21/1472	118/5963	0.97211319023411	0.999999999999965	0.819576616818771	10973/57198/22943/1844/1846/1847/2627/6928/3915/51176/10459/83881/5460/5744/23682/64321/6772/30009/6925/55809/10451	21
WP2507	Nanomaterial induced apoptosis	2/1472	20/5963	0.974125655947348	0.999999999999965	0.819576616818771	841/5551	2
WP4725	Sphingolipid metabolism overview	2/1472	20/5963	0.974125655947348	0.999999999999965	0.819576616818771	259230/8877	2
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	1/1472	13/5963	0.975022316188504	0.999999999999965	0.819576616818771	25939	1
WP5037	Riboflavin and CoQ disorders	1/1472	13/5963	0.975022316188504	0.999999999999965	0.819576616818771	55065	1
WP1544	MicroRNAs in cardiomyocyte hypertrophy	13/1472	80/5963	0.97514624902112	0.999999999999965	0.819576616818771	183/1906/2247/51564/3572/3084/5293/8503/5320/5579/6774/7124/7474	13
WP35	G protein signaling pathways	14/1472	85/5963	0.975221594647015	0.999999999999965	0.819576616818771	196883/9472/9465/2769/2784/10681/51764/2786/3760/5153/5137/5142/5577/5579	14
WP4657	22q11.2 copy number variation syndrome	15/1472	90/5963	0.975401988749821	0.999999999999965	0.819576616818771	8854/8659/8318/8646/9076/56603/2255/2296/4942/5308/5347/5625/6097/6469/7450	15
WP4971	Phosphoinositides metabolism	6/1472	44/5963	0.976443328733807	0.999999999999965	0.819576616818771	3635/5288/5293/23236/5333/5336	6
WP3996	Ethanol effects on histone modifications	3/1472	27/5963	0.977680422671913	0.999999999999965	0.819576616818771	126/8854/51564	3
WP5102	Familial partial lipodystrophy (FPLD)	3/1472	27/5963	0.977680422671913	0.999999999999965	0.819576616818771	10365/4023/5396	3
WP4932	7q11.23 copy number variation syndrome	14/1472	86/5963	0.978312007289697	0.999999999999965	0.819576616818771	64756/695/9076/2006/2200/7462/3984/51085/3084/5313/6616/9246/155382/7472	14
WP2526	PDGF pathway	5/1472	39/5963	0.978774786113596	0.999999999999965	0.819576616818771	5155/5159/6772/6774/7409	5
WP5085	Vasopressin-regulated water reabsorption	5/1472	39/5963	0.978774786113596	0.999999999999965	0.819576616818771	397/398/64764/84699/9586	5
WP4726	Sphingolipid metabolism: integrated pathway	2/1472	21/5963	0.979685475458358	0.999999999999965	0.819576616818771	259230/8877	2
WP4928	MAPK pathway in congenital thyroid cancer	1/1472	14/5963	0.981201669225567	0.999999999999965	0.819576616818771	8844	1
WP313	Hepatocyte growth factor receptor signaling	4/1472	34/5963	0.981800129293423	0.999999999999965	0.819576616818771	3082/3672/11184/6774	4
WP4312	Rett syndrome causing genes	5/1472	40/5963	0.982442449763317	0.999999999999965	0.819576616818771	3766/23314/85358/23224/6925	5
WP45	G1 to S cell cycle control	9/1472	62/5963	0.982796177593612	0.999999999999965	0.819576616818771	891/898/8318/983/1029/1030/84699/4998/23594	9
WP4566	Translation inhibitors in chronically activated PDGFRA cells	6/1472	46/5963	0.983539729215396	0.999999999999965	0.819576616818771	10000/27250/5163/8503/11040/6196	6
WP4659	Gastrin signaling pathway	18/1472	108/5963	0.983710559619409	0.999999999999965	0.819576616818771	302/330/332/960/1029/1113/9076/2534/51564/3067/3717/4316/8503/5743/5054/6774/6925/7032	18
WP4262	Breast cancer pathway	22/1472	129/5963	0.986386171762701	0.999999999999965	0.819576616818771	10000/672/675/2246/2255/2247/2252/2254/2324/11211/23493/51176/4791/4854/4855/5293/8503/25759/7480/7481/7472/7474	22
WP3959	DNA IR-double strand breaks and cellular response via ATM	7/1472	53/5963	0.98727233381869	0.999999999999965	0.819576616818771	641/672/675/1029/9156/6788/7161	7
WP4205	MET in type 1 papillary renal cell carcinoma	7/1472	53/5963	0.98727233381869	0.999999999999965	0.819576616818771	10000/2113/3082/3718/5293/8503/6774	7
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	4/1472	36/5963	0.987928270728293	0.999999999999965	0.819576616818771	3488/5163/10891/8744	4
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	3/1472	30/5963	0.988496853594663	0.999999999999965	0.819576616818771	4846/5163/8503	3
WP195	IL-1 signaling pathway	7/1472	54/5963	0.989336449138074	0.999999999999965	0.819576616818771	6347/3552/3553/3554/3556/3656/11213	7
WP1545	miRNAs involved in DNA damage response	1/1472	16/5963	0.989354120879808	0.999999999999965	0.819576616818771	898	1
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	1/1472	16/5963	0.989354120879808	0.999999999999965	0.819576616818771	5105	1
WP481	Insulin signaling	27/1472	156/5963	0.990220022143455	0.999999999999965	0.819576616818771	30846/5167/9064/1326/11184/9448/5600/6300/5288/5293/8503/5579/5880/5967/57381/23433/6196/27330/10110/10603/25759/6513/6616/8651/9021/57761/7494	27
WP4521	Glycosylation and related congenital defects	2/1472	24/5963	0.990268151604831	0.999999999999965	0.819576616818771	2683/79644	2
WP2637	Interleukin-1 (IL-1) structural pathway	6/1472	49/5963	0.990536168826214	0.999999999999965	0.819576616818771	3552/3554/3556/3656/1326/5600	6
WP231	TNF-alpha signaling pathway	14/1472	92/5963	0.990582905076121	0.999999999999965	0.819576616818771	330/841/6347/3569/8844/283455/1326/4791/5347/6401/7124/7128/7133/7185	14
WP2261	Glioblastoma signaling pathways	12/1472	82/5963	0.991076233765444	0.999999999999965	0.819576616818771	10000/672/675/898/1029/1030/54206/5159/5288/5293/5336/5579	12
WP4155	Endometrial cancer	8/1472	61/5963	0.991729628209526	0.999999999999965	0.819576616818771	10000/1496/2246/2247/2261/51176/5293/8503	8
WP4674	Head and neck squamous cell carcinoma	10/1472	72/5963	0.991877125816516	0.999999999999965	0.819576616818771	84962/10000/841/1029/54541/2261/4791/23533/7015/8626	10
WP4861	Endoplasmic reticulum stress response in coronavirus infection	5/1472	44/5963	0.991951130239767	0.999999999999965	0.819576616818771	3309/26051/84152/79660/7494	5
WP391	Mitochondrial gene expression	1/1472	17/5963	0.991989186301856	0.999999999999965	0.819576616818771	10891	1
WP5200	Dravet syndrome	1/1472	17/5963	0.991989186301856	0.999999999999965	0.819576616818771	5600	1
WP3965	Lipid metabolism pathway	2/1472	25/5963	0.992407957165361	0.999999999999965	0.819576616818771	10000/5577	2
WP4022	Pyrimidine metabolism	11/1472	79/5963	0.993759306963075	0.999999999999965	0.819576616818771	1503/5167/953/956/56953/10622/6241/7083/1890/7371/7378	11
WP3879	4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression	1/1472	18/5963	0.993972354442399	0.999999999999965	0.819576616818771	55872	1
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/1472	18/5963	0.993972354442399	0.999999999999965	0.819576616818771	22808	1
WP734	Serotonin receptor 4/6/7 and NR3C signaling	1/1472	18/5963	0.993972354442399	0.999999999999965	0.819576616818771	3363	1
WP3981	miRNA regulation of prostate cancer signaling pathways	3/1472	33/5963	0.994171260683885	0.999999999999965	0.819576616818771	10000/354/5159	3
WP4874	CAMKK2 pathway	3/1472	33/5963	0.994171260683885	0.999999999999965	0.819576616818771	1131/3383/7412	3
WP2446	Retinoblastoma gene in cancer	12/1472	86/5963	0.995201086101478	0.999999999999965	0.819576616818771	54443/890/891/898/994/8318/8317/983/24137/4998/6241/7272	12
WP400	p38 MAPK signaling pathway	3/1472	34/5963	0.995368466947478	0.999999999999965	0.819576616818771	3315/6772/7042	3
WP384	Apoptosis modulation by HSP70	1/1472	19/5963	0.995464817732691	0.999999999999965	0.819576616818771	841	1
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/1472	19/5963	0.995464817732691	0.999999999999965	0.819576616818771	10125	1
WP2795	Cardiac hypertrophic response	6/1472	53/5963	0.995593562698333	0.999999999999965	0.819576616818771	2247/51564/11184/3084/5320/7124	6
WP268	Notch signaling	4/1472	41/5963	0.995818191130534	0.999999999999965	0.819576616818771	151636/4242/4854/4855	4
WP4838	Regucalcin in proximal tubule epithelial kidney cells	2/1472	28/5963	0.996422852510219	0.999999999999965	0.819576616818771	841/5153	2
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/1472	20/5963	0.996587931510867	0.999999999999965	0.819576616818771	3002	1
WP3878	ATM signaling in development and disease 	4/1472	42/5963	0.996634420901138	0.999999999999965	0.819576616818771	9212/699/983/3315	4
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	4/1472	42/5963	0.996634420901138	0.999999999999965	0.819576616818771	196883/23224/7042/7043	4
WP366	TGF-beta signaling pathway	20/1472	130/5963	0.996642199564817	0.999999999999965	0.819576616818771	467/857/983/1030/1278/2113/50943/3673/3690/3726/11184/4312/4321/5163/5371/150094/6498/7015/3371/6935	20
WP673	ErbB signaling pathway	11/1472	83/5963	0.996748862271597	0.999999999999965	0.819576616818771	10000/816/1839/3084/145957/5293/8503/5336/5579/25759/6776	11
WP363	Wnt signaling pathway	5/1472	49/5963	0.997087561711474	0.999999999999965	0.819576616818771	2697/51176/5579/6925/7010	5
WP2447	Amyotrophic lateral sclerosis (ALS)	3/1472	36/5963	0.997088702730958	0.999999999999965	0.819576616818771	834/5630/7124	3
WP4549	Fragile X syndrome	14/1472	101/5963	0.9975664635488	0.999999999999965	0.819576616818771	27161/7915/816/1029/1759/1979/54869/2534/80852/9456/4318/5163/23236/6566	14
WP707	DNA damage response	7/1472	62/5963	0.99757162303305	0.999999999999965	0.819576616818771	672/841/891/898/983/5366/5371	7
WP4685	Melanoma	7/1472	63/5963	0.997996215425013	0.999999999999965	0.819576616818771	10000/1029/2113/3791/5293/8503/25759	7
WP61	Notch signaling pathway	6/1472	57/5963	0.998002310342483	0.999999999999965	0.819576616818771	23493/3091/3717/4854/4855/6774	6
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	1/1472	22/5963	0.998068958731288	0.999999999999965	0.819576616818771	51176	1
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	20/1472	134/5963	0.998076172833565	0.999999999999965	0.819576616818771	249/55816/1959/2534/2562/2892/3717/3738/3781/8844/84894/653361/4688/10603/25759/6696/6772/6774/6776/10451	20
WP2034	Leptin signaling pathway	9/1472	75/5963	0.998124178138567	0.999999999999965	0.819576616818771	2534/3553/3557/3717/4846/5336/9021/6772/6774	9
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	2/1472	31/5963	0.998331117277319	0.999999999999965	0.819576616818771	51564/4772	2
WP4263	Pancreatic adenocarcinoma pathway	11/1472	87/5963	0.998345055682669	0.999999999999965	0.819576616818771	10000/9459/675/1029/5293/8503/5880/6772/6774/7042/7043	11
WP5180	DYRK1A	6/1472	58/5963	0.998366953021501	0.999999999999965	0.819576616818771	273/1759/2247/3092/26524/4772	6
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	8/1472	70/5963	0.998376380676711	0.999999999999965	0.819576616818771	10000/332/51176/5366/5743/5880/7042/7043	8
WP531	DNA mismatch repair	1/1472	23/5963	0.99854741231613	0.999999999999965	0.819576616818771	9156	1
WP437	EGF/EGFR signaling pathway	24/1472	157/5963	0.998647642936575	0.999999999999965	0.819576616818771	50807/6790/857/1759/9046/54206/2697/3635/3717/11184/4605/4846/5359/5579/7837/6196/9047/6456/6772/6774/6776/7291/7409/10451	24
WP183	Proteasome degradation	6/1472	59/5963	0.998666927885863	0.999999999999965	0.819576616818771	3134/3458/5684/5696/5698/5721	6
WP5202	Alstrom syndrome	2/1472	32/5963	0.998708107260598	0.999999999999965	0.819576616818771	84984/26052	2
WP1530	miRNA regulation of DNA damage response	7/1472	66/5963	0.998883830296565	0.999999999999965	0.819576616818771	672/841/891/898/983/5366/5371	7
WP4949	16p11.2 proximal deletion syndrome	7/1472	67/5963	0.99908412266614	0.999999999999965	0.819576616818771	283897/841/11151/8448/3486/4478/23475	7
WP1471	Target of rapamycin (TOR) signaling	2/1472	35/5963	0.99940373707721	0.999999999999965	0.819576616818771	54541/3422	2
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	6/1472	64/5963	0.99952629202424	0.999999999999965	0.819576616818771	898/3717/23236/6772/6774/7253	6
WP4204	Tumor suppressor activity of SMARCB1	1/1472	27/5963	0.999535158767528	0.999999999999965	0.819576616818771	1029	1
WP623	Oxidative phosphorylation	2/1472	36/5963	0.999539915568166	0.999999999999965	0.819576616818771	3002/56901	2
WP138	Androgen receptor signaling pathway	9/1472	85/5963	0.999711333181437	0.999999999999965	0.819576616818771	672/811/857/898/2274/2316/354/8431/6774	9
WP3676	BDNF-TrkB signaling	1/1472	29/5963	0.999737129953959	0.999999999999965	0.819576616818771	9456	1
WP722	Serotonin HTR1 group and FOS pathway	1/1472	29/5963	0.999737129953959	0.999999999999965	0.819576616818771	10125	1
WP4396	Nonalcoholic fatty liver disease	17/1472	137/5963	0.999900387911788	0.999999999999965	0.819576616818771	10000/841/6347/84701/3552/3553/3569/51085/56901/9971/5293/8503/5313/9021/7124/7412/7494	17
WP3651	Pathways affected in adenoid cystic carcinoma	4/1472	58/5963	0.999912414758475	0.999999999999965	0.819576616818771	672/93986/4613/29128	4
WP422	MAPK cascade	1/1472	33/5963	0.9999159912999	0.999999999999965	0.819576616818771	6300	1
WP2369	Histone modifications	1/1472	35/5963	0.999952524360954	0.999999999999965	0.819576616818771	80854	1
WP2059	Alzheimer's disease and miRNA effects	32/1472	229/5963	0.999982737909708	0.999999999999965	0.819576616818771	177/10000/775/841/1139/1536/22943/11211/2906/3552/3553/3569/3800/4023/407024/4311/4843/5293/8503/23236/5684/5743/7124/79861/7280/10381/84617/7480/7481/7472/7474/7494	32
WP107	Translation factors	2/1472	49/5963	0.999985031770841	0.999999999999965	0.819576616818771	1917/1979	2
WP3680	Physico-chemical features and toxicity-associated pathways	3/1472	58/5963	0.999986661444754	0.999999999999965	0.819576616818771	11211/6776/7481	3
WP5124	Alzheimer's disease	31/1472	226/5963	0.999987726997305	0.999999999999965	0.819576616818771	177/10000/775/841/1139/1536/22943/11211/2906/3552/3553/3569/3800/4023/4311/4843/5293/8503/23236/5684/5743/7124/79861/7280/10381/84617/7480/7481/7472/7474/7494	31
WP405	Eukaryotic transcription initiation	1/1472	41/5963	0.99999144284377	0.999999999999965	0.819576616818771	2966	1
WP4753	Nucleotide excision repair	1/1472	43/5963	0.999995168428469	0.999999999999965	0.819576616818771	2966	1
WP4656	Joubert syndrome	4/1472	71/5963	0.999996203460655	0.999999999999965	0.819576616818771	27077/2316/5145/6469	4
WP1541	Energy metabolism	1/1472	44/5963	0.999996369792201	0.999999999999965	0.819576616818771	10891	1
WP5114	Nucleotide excision repair in xeroderma pigmentosum 	2/1472	57/5963	0.999998250406765	0.999999999999965	0.819576616818771	672/2966	2
WP4536	Genes related to primary cilium development (based on CRISPR)	4/1472	88/5963	0.999999946259215	0.999999999999965	0.819576616818771	27077/23552/84984/51715	4
WP4946	DNA repair pathways, full network	6/1472	112/5963	0.999999992447658	0.999999999999965	0.819576616818771	672/675/9156/2175/2187/2966	6
WP477	Cytoplasmic ribosomal proteins	2/1472	86/5963	0.999999999374086	0.999999999999965	0.819576616818771	6196/27330	2
WP4803	Ciliopathies	8/1472	139/5963	0.999999999550975	0.999999999999965	0.819576616818771	122481/27077/10309/84984/1259/1768/4751/51715	8
WP4352	Ciliary landscape	11/1472	201/5963	0.999999999999965	0.999999999999965	0.819576616818771	26286/875/9859/30845/128239/3934/55388/2040/7020/339488/7431	11
